{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:59:55Z","timestamp":1790787595653,"version":"4.1.0"},"reference-count":342,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013078","name":"Natural Science Research Project of Guizhou Province","doi-asserted-by":"publisher","award":["QKH-JC-ZK[2021]ZD018"],"award-info":[{"award-number":["QKH-JC-ZK[2021]ZD018"]}],"id":[{"id":"10.13039\/501100013078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Prod. Bioprospect."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s13659-026-00641-z","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:05:48Z","timestamp":1790741148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the tumor microenvironment: a new strategy for natural products in breast cancer therapy"],"prefix":"10.1007","volume":"16","author":[{"given":"Yan-Cai","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"3","key":"641_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"641_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1483459","volume":"15","author":"L Fang","year":"2024","unstructured":"Fang L, Gao D, Wang T, Zhao H, Zhang Y, Wang S. From nature to clinic: Quercetin\u2019s role in breast cancer immunomodulation. Front Immunol. 2024;15:1483459. https:\/\/doi.org\/10.3389\/fimmu.2024.1483459.","journal-title":"Front Immunol"},{"issue":"10286","key":"641_CR3","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/s0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;397(10286):1750\u201369. https:\/\/doi.org\/10.1016\/s0140-6736(20)32381-3.","journal-title":"Lancet"},{"key":"641_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","volume":"60","author":"Y Liang","year":"2020","unstructured":"Liang Y, Zhang H, Song X, Yang Q. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020;60:14\u201327. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.012.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"641_CR5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","volume":"37","author":"AB Hanker","year":"2020","unstructured":"Hanker AB, Sudhan DR, Arteaga CL. Overcoming endocrine resistance in breast cancer. Cancer Cell. 2020;37(4):496\u2013513. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.009.","journal-title":"Cancer Cell"},{"key":"641_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17172794","author":"AL Hilliard","year":"2025","unstructured":"Hilliard AL, Russell TD, Mendonca P, Soliman KFA. Targeting the tumor immune microenvironment in triple-negative breast cancer: the promise of polyphenols. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17172794.","journal-title":"Cancers (Basel)"},{"issue":"16","key":"641_CR7","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Zhang H, Sun Y, Liu R, Hamdy H, Shi Z, Jiang D, et al. The role of tumor microenvironment and signaling pathways in regulating breast cancer stem cells: Implications for therapy resistance and tumor recurrence. Drug Resist Updat. 2026;84:101315.https:\/\/doi.org\/10.1016\/j.drup.2025.101315","journal-title":"Curr Biol"},{"issue":"4","key":"641_CR8","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.Cd-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 2021;11(4):933\u201359. https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-1808.","journal-title":"Cancer Discov"},{"issue":"6","key":"641_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Baldasici O, Soritau O, Roman A, Lisencu C, Visan S, Maja L, et al. The transcriptional landscape of cancer stem-like cell functionality in breast cancer. J Transl Med. 2024;22(1):530.https:\/\/doi.org\/10.1186\/s12967-024-05281-w","journal-title":"Mol Cell"},{"key":"641_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1525052","volume":"16","author":"W Xia","year":"2025","unstructured":"Xia W, Tan Y, Liu Y, Xie N, Zhu H. Prospect of extracellular vesicles in tumor immunotherapy. Front Immunol. 2025;16:1525052. https:\/\/doi.org\/10.3389\/fimmu.2025.1525052.","journal-title":"Front Immunol"},{"issue":"9","key":"641_CR11","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53(9):1334\u201347. https:\/\/doi.org\/10.1038\/s41588-021-00911-1.","journal-title":"Nat Genet"},{"key":"641_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1280601","volume":"14","author":"A Hazrati","year":"2023","unstructured":"Hazrati A, Malekpour K, Mirsanei Z, Khosrojerdi A, Rahmani-Kukia N, Heidari N, et al. Cancer-associated mesenchymal stem\/stromal cells: role in progression and potential targets for therapeutic approaches. Front Immunol. 2023;14:1280601. https:\/\/doi.org\/10.3389\/fimmu.2023.1280601.","journal-title":"Front Immunol"},{"key":"641_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1410300","volume":"15","author":"A Alqathama","year":"2024","unstructured":"Alqathama A. Natural products as promising modulators of breast cancer immunotherapy. Front Immunol. 2024;15:1410300. https:\/\/doi.org\/10.3389\/fimmu.2024.1410300.","journal-title":"Front Immunol"},{"issue":"2","key":"641_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11101-021-09785-x","volume":"21","author":"G Renda","year":"2022","unstructured":"Renda G, G\u00f6kkaya \u0130, \u015e\u00f6hreto\u011flu D. Immunomodulatory properties of triterpenes. Phytochem Rev. 2022;21(2):537\u201363. https:\/\/doi.org\/10.1007\/s11101-021-09785-x.","journal-title":"Phytochem Rev"},{"key":"641_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165718","author":"M \u00c1vila-G\u00e1lvez","year":"2020","unstructured":"\u00c1vila-G\u00e1lvez M, Gim\u00e9nez-Bastida JA, Esp\u00edn JC, Gonz\u00e1lez-Sarr\u00edas A. Dietary phenolics against breast cancer. A critical evidence-based review and future perspectives. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21165718.","journal-title":"Int J Mol Sci"},{"key":"641_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.909566","volume":"13","author":"R De Sanctis","year":"2022","unstructured":"De Sanctis R, Jacobs F, Benvenuti C, Gaudio M, Franceschini R, Tancredi R, et al. From seaside to bedside: current evidence and future perspectives in the treatment of breast cancer using marine compounds. Front Pharmacol. 2022;13:909566. https:\/\/doi.org\/10.3389\/fphar.2022.909566.","journal-title":"Front Pharmacol"},{"key":"641_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nu16234143","author":"E Eren","year":"2024","unstructured":"Eren E, Das J, Tollefsbol TO. Polyphenols as immunomodulators and epigenetic modulators: an analysis of their role in the treatment and prevention of breast cancer. Nutrients. 2024. https:\/\/doi.org\/10.3390\/nu16234143.","journal-title":"Nutrients"},{"key":"641_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.743837","volume":"12","author":"S He","year":"2021","unstructured":"He S, Wang S, Liu S, Li Z, Liu X, Wu J. Baicalein potentiated M1 macrophage polarization in cancer through targeting PI3K\u03b3\/ NF-\u03baB signaling. Front Pharmacol. 2021;12:743837. https:\/\/doi.org\/10.3389\/fphar.2021.743837.","journal-title":"Front Pharmacol"},{"key":"641_CR19","doi-asserted-by":"publisher","unstructured":"Hu H, Wang Q, Yu D, Tao X, Guo M, Tian S, et al. Berberine derivative B68 promotes tumor immune clearance by dual-targeting BMI1 for senescence induction and CSN5 for PD-L1 degradation. Adv Sci (Weinh). 2025;12(7):e2413122. https:\/\/doi.org\/10.1002\/advs.202413122","DOI":"10.1002\/advs.202413122"},{"issue":"1","key":"641_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-023-00822-9","volume":"18","author":"RY Jiang","year":"2023","unstructured":"Jiang RY, Fang ZR, Zhang HP, Xu JY, Zhu JY, Chen KY, et al. Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer. Chin Med. 2023;18(1):125. https:\/\/doi.org\/10.1186\/s13020-023-00822-9.","journal-title":"Chin Med"},{"issue":"1","key":"641_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00855-6","volume":"29","author":"LM Chen","year":"2022","unstructured":"Chen LM, Yang PP, Al Haq AT, Hwang PA, Lai YC, Weng YS, et al. Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice. J Biomed Sci. 2022;29(1):70. https:\/\/doi.org\/10.1186\/s12929-022-00855-6.","journal-title":"J Biomed Sci"},{"key":"641_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ph18101486","author":"P Uniyal","year":"2025","unstructured":"Uniyal P, Akhtar A, Rawat R. Flavonoid-based combination therapies and nano-formulations: an emerging frontier in breast cancer treatment. Pharmaceuticals (Basel). 2025. https:\/\/doi.org\/10.3390\/ph18101486.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"641_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s13167-025-00407-6","volume":"16","author":"P Kubatka","year":"2025","unstructured":"Kubatka P, Bojkova B, Nosalova N, Huniadi M, Samuel SM, Sreenesh B, et al. Targeting the MAPK signaling pathway: implications and prospects of flavonoids in 3P medicine as modulators of cancer cell plasticity and therapeutic resistance in breast cancer patients. EPMA J. 2025;16(2):437\u201363. https:\/\/doi.org\/10.1007\/s13167-025-00407-6.","journal-title":"EPMA J"},{"issue":"1","key":"641_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-11231-6","volume":"53","author":"M Sharma","year":"2025","unstructured":"Sharma M, Kumar U, Singh S. Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights. Mol Biol Rep. 2025;53(1):41. https:\/\/doi.org\/10.1007\/s11033-025-11231-6.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"641_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01990-4","volume":"23","author":"M Kundu","year":"2024","unstructured":"Kundu M, Butti R, Panda VK, Malhotra D, Das S, Mitra T, et al. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer. Mol Cancer. 2024;23(1):92. https:\/\/doi.org\/10.1186\/s12943-024-01990-4.","journal-title":"Mol Cancer"},{"key":"641_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117714","volume":"181","author":"J Yuan","year":"2024","unstructured":"Yuan J, Yang L, Zhang H, Beeraka NM, Zhang D, Wang Q, et al. Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers. Biomed Pharmacother. 2024;181:117714. https:\/\/doi.org\/10.1016\/j.biopha.2024.117714.","journal-title":"Biomed Pharmacother"},{"key":"641_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1550003","volume":"16","author":"T Xu","year":"2025","unstructured":"Xu T, Zhang H, Yang BB, Qadir J, Yuan H, Ye T. Tumor-infiltrating immune cells state-implications for various breast cancer subtypes. Front Immunol. 2025;16:1550003. https:\/\/doi.org\/10.3389\/fimmu.2025.1550003.","journal-title":"Front Immunol"},{"issue":"3","key":"641_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32030143","volume":"32","author":"T Moura","year":"2025","unstructured":"Moura T, Laranjeira P, Caramelo O, Gil AM, Paiva A. Breast Cancer and tumor microenvironment: the crucial role of immune cells. Curr Oncol. 2025;32(3):0143. https:\/\/doi.org\/10.3390\/curroncol32030143.","journal-title":"Curr Oncol"},{"key":"641_CR29","doi-asserted-by":"crossref","unstructured":"Tharp KM, Kersten K, Maller O, Timblin GA, Stashko C, Canale FP, et al. Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nat Cancer. 2024;5(7):1045\u201362.https:\/\/doi.org\/10.1038\/s43018-024-00775-4","DOI":"10.1038\/s43018-024-00775-4"},{"issue":"18","key":"641_CR30","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1158\/0008-5472.Can-22-1427","volume":"82","author":"E Timperi","year":"2022","unstructured":"Timperi E, Gueguen P, Molgora M, Magagna I, Kieffer Y, Lopez-Lastra S, et al. Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in Breast Cancer. Cancer Res. 2022;82(18):3291\u2013306. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-1427.","journal-title":"Cancer Res"},{"issue":"4","key":"641_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.immuni.2025.03.002","volume":"58","author":"L Yu","year":"2025","unstructured":"Yu L, Liebenberg K, Shen Y, Liu F, Xu Z, Hao X, et al. Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative Breast Cancer. Immunity. 2025;58(4):909-25.e7. https:\/\/doi.org\/10.1016\/j.immuni.2025.03.002.","journal-title":"Immunity"},{"issue":"6","key":"641_CR32","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1158\/2159-8290.Cd-24-0131","volume":"15","author":"A Ben-Shmuel","year":"2025","unstructured":"Ben-Shmuel A, Gruper Y, Halperin C, Levi-Galibov O, Rosenberg-Fogler H, Barki D, et al. Cancer-associated fibroblasts serve as decoys to suppress NK cell anticancer cytotoxicity in Breast Cancer. Cancer Discov. 2025;15(6):1247\u201369. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-0131.","journal-title":"Cancer Discov"},{"issue":"10","key":"641_CR33","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s43018-025-01007-z","volume":"6","author":"G Petroni","year":"2025","unstructured":"Petroni G, Galassi C, Gouin KH 3rd, Chen HH, Buqu\u00e9 A, Bloy N, et al. IL-17A-secreting \u03b3\u03b4 T cells promote resistance to CDK4\/CDK6 inhibitors in HR(+)HER2(-) breast cancer via CX3CR1(+) macrophages. Nat Cancer. 2025;6(10):1656\u201375. https:\/\/doi.org\/10.1038\/s43018-025-01007-z.","journal-title":"Nat Cancer"},{"issue":"2","key":"641_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189291","volume":"1880","author":"J Yang","year":"2025","unstructured":"Yang J, Xin B, Wang X, Wan Y. Cancer-associated fibroblasts in Breast Cancer in the single-cell era: opportunities and challenges. Biochim Biophys Acta Rev Cancer. 2025;1880(2):189291. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189291.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"641_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47068-z","volume":"15","author":"H Croizer","year":"2024","unstructured":"Croizer H, Mhaidly R, Kieffer Y, Gentric G, Djerroudi L, Leclere R, et al. Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in Breast Cancer. Nat Commun. 2024;15(1):2806. https:\/\/doi.org\/10.1038\/s41467-024-47068-z.","journal-title":"Nat Commun"},{"issue":"7","key":"641_CR36","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/2159-8290.Cd-23-0426","volume":"14","author":"J Ye","year":"2024","unstructured":"Ye J, Baer JM, Faget DV, Morikis VA, Ren Q, Melam A, et al. Senescent CAFs mediate immunosuppression and drive Breast Cancer progression. Cancer Discov. 2024;14(7):1302\u201323. https:\/\/doi.org\/10.1158\/2159-8290.Cd-23-0426.","journal-title":"Cancer Discov"},{"key":"641_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115183","author":"L Jahangiri","year":"2025","unstructured":"Jahangiri L. The mechanical properties of breast cancer cells and their surrounding microenvironment. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26115183.","journal-title":"Int J Mol Sci"},{"key":"641_CR38","doi-asserted-by":"publisher","unstructured":"Han B, Guan X, Ma M, Liang B, Ren L, Liu Y, et al. Stiffened tumor microenvironment enhances perineural invasion in breast cancer via integrin signaling. Cell Oncol (Dordr). 2024;47(3):867\u201382. https:\/\/doi.org\/10.1007\/s13402-023-00901-x","DOI":"10.1007\/s13402-023-00901-x"},{"issue":"1","key":"641_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-02017-6","volume":"27","author":"S Heydari","year":"2025","unstructured":"Heydari S, Tajik F, Safaei S, Kamani F, Karami B, Dorafshan S, et al. The association between tumor-stromal collagen features and the clinical outcomes of patients with breast cancer: a systematic review. Breast Cancer Res. 2025;27(1):69. https:\/\/doi.org\/10.1186\/s13058-025-02017-6.","journal-title":"Breast Cancer Res"},{"issue":"741","key":"641_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj5705","volume":"16","author":"G Fan","year":"2024","unstructured":"Fan G, Yu B, Tang L, Zhu R, Chen J, Zhu Y, et al. TSPAN8(+) myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer. Sci Transl Med. 2024;16(741):eadj5705. https:\/\/doi.org\/10.1126\/scitranslmed.adj5705.","journal-title":"Sci Transl Med"},{"key":"641_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.matbio.2025.05.004","volume":"139","author":"J Martin","year":"2025","unstructured":"Martin J, Falaise A, Faour S, Terryn C, Hachet C, Thi\u00e9bault \u00c9, et al. Differential modulation of endothelial cell functionality by LRP1 expression in fibroblasts and cancer-associated fibroblasts via paracrine signals and matrix remodeling. Matrix Biol. 2025;139:61\u201376. https:\/\/doi.org\/10.1016\/j.matbio.2025.05.004.","journal-title":"Matrix Biol"},{"issue":"1","key":"641_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58511-0","volume":"16","author":"X Wang","year":"2025","unstructured":"Xiao Z, Todd L, Huang L, Noguera-Ortega E, Lu Z, Huang L, et al. Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors. Nat Commun. 2023;14(1):5110.https:\/\/doi.org\/10.1038\/s41467-023-40850-5","journal-title":"Nat Commun"},{"issue":"7","key":"641_CR43","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","volume":"20","author":"T Yoshimura","year":"2023","unstructured":"Yoshimura T, Li C, Wang Y, Matsukawa A. The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell Mol Immunol. 2023;20(7):714\u201338. https:\/\/doi.org\/10.1038\/s41423-023-01013-0.","journal-title":"Cell Mol Immunol"},{"key":"641_CR44","doi-asserted-by":"publisher","unstructured":"Habanjar O, Bingula R, Decombat C, Diab-Assaf M, Caldefie-Chezet F, Delort L. Crosstalk of inflammatory cytokines within the breast tumor microenvironment. Int jJ Mol Sci. 2023;24(4). https:\/\/doi.org\/10.3390\/ijms24044002","DOI":"10.3390\/ijms24044002"},{"issue":"1","key":"641_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01644-1","volume":"25","author":"S Lee","year":"2023","unstructured":"Lee S, Toft NJ, Axelsen TV, Espejo MS, Pedersen TM, Mele M, et al. Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2\/HER2-enriched breast cancer. Breast Cancer Res. 2023;25(1):46. https:\/\/doi.org\/10.1186\/s13058-023-01644-1.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"641_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02258-1","volume":"24","author":"M Wan","year":"2025","unstructured":"Wan M, Pan S, Shan B, Diao H, Jin H, Wang Z, et al. Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment. Mol Cancer. 2025;24(1):61. https:\/\/doi.org\/10.1186\/s12943-025-02258-1.","journal-title":"Mol Cancer"},{"key":"641_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215616","volume":"534","author":"X Lyu","year":"2022","unstructured":"Lyu X, Zhang Q, Fares HM, Wang Y, Han Y, Sun L. Contribution of adipocytes in the tumor microenvironment to breast cancer metabolism. Cancer Lett. 2022;534:215616. https:\/\/doi.org\/10.1016\/j.canlet.2022.215616.","journal-title":"Cancer Lett"},{"issue":"7","key":"641_CR48","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.scib.2024.12.039","volume":"70","author":"J Xia","year":"2025","unstructured":"Xia J, Zhang L, Zhu W, Tu J, Peng X, Deng Q, et al. Tumor cell-derived N-acetyl-aspartyl-glutamate reshapes the tumor microenvironment to facilitate breast cancer metastasis. Sci Bull. 2025;70(7):1126\u201338. https:\/\/doi.org\/10.1016\/j.scib.2024.12.039.","journal-title":"Sci Bull"},{"key":"641_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/genes13091585","author":"Y Dekker","year":"2022","unstructured":"Dekker Y, Le D\u00e9v\u00e9dec SE, Danen EHJ, Liu Q. Crosstalk between hypoxia and extracellular matrix in the tumor microenvironment in breast cancer. Genes (Basel). 2022. https:\/\/doi.org\/10.3390\/genes13091585.","journal-title":"Genes (Basel)"},{"issue":"3","key":"641_CR50","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/jleuko\/qiae065","volume":"116","author":"D Zhang","year":"2024","unstructured":"Zhang D, Wang M, Wang W, Ma S, Yu W, Ren X, et al. PGAM1 suppression remodels the tumor microenvironment in triple-negative breast cancer and synergizes with anti-PD-1 immunotherapy. J Leukoc Biol. 2024;116(3):579\u201388. https:\/\/doi.org\/10.1093\/jleuko\/qiae065.","journal-title":"J Leukoc Biol"},{"key":"641_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/genes14010044","author":"J Li","year":"2022","unstructured":"Li J, Wu J, Han J. Analysis of tumor microenvironment heterogeneity among breast cancer subtypes to identify subtype-specific signatures. Genes (Basel). 2022. https:\/\/doi.org\/10.3390\/genes14010044.","journal-title":"Genes (Basel)"},{"key":"641_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ph19020314","author":"ZA Mao","year":"2026","unstructured":"Mao ZA, Zhang ML, An ZY, Jin WL. Systematic investigation of tumor immune microenvironment modulation by Cynomorium songaricum against breast cancer through integrated chemomics, network pharmacology and molecular docking. Pharmaceuticals (Basel). 2026. https:\/\/doi.org\/10.3390\/ph19020314.","journal-title":"Pharmaceuticals (Basel)"},{"key":"641_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00348","volume":"10","author":"M Segovia-Mendoza","year":"2019","unstructured":"Segovia-Mendoza M, Morales-Montor J. Immune tumor microenvironment in breast cancer and the participation of estrogen and its receptors in cancer physiopathology. Front Immunol. 2019;10:348. https:\/\/doi.org\/10.3389\/fimmu.2019.00348.","journal-title":"Front Immunol"},{"issue":"11","key":"641_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1483","volume":"13","author":"X Li","year":"2023","unstructured":"Li X, Chen G, Wang F, Guo X, Zhang R, Liu P, et al. Oncogenic PIK3CA recruits myeloid-derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5-lipoxygenase-dependent arachidonic acid pathway. Clin Transl Med. 2023;13(11):e1483. https:\/\/doi.org\/10.1002\/ctm2.1483.","journal-title":"Clin Transl Med"},{"issue":"11","key":"641_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.577","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhang J, Zhang M, Song Y, Zhang Y, Fan S, et al. Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1\u03b1. Clin Transl Med. 2021;11(11):e577. https:\/\/doi.org\/10.1002\/ctm2.577.","journal-title":"Clin Transl Med"},{"issue":"15","key":"641_CR56","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.7150\/thno.43622","volume":"10","author":"G Zou","year":"2020","unstructured":"Zou G, Zhang X, Wang L, Li X, Xie T, Zhao J, et al. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription. Theranostics. 2020;10(15):6839\u201353. https:\/\/doi.org\/10.7150\/thno.43622.","journal-title":"Theranostics"},{"issue":"2","key":"641_CR57","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.18632\/oncotarget.13159","volume":"8","author":"AK Wege","year":"2017","unstructured":"Wege AK, Weber F, Kroemer A, Ortmann O, Nimmerjahn F, Brockhoff G. IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM). Oncotarget. 2017;8(2):2731\u201344. https:\/\/doi.org\/10.18632\/oncotarget.13159.","journal-title":"Oncotarget"},{"issue":"9","key":"641_CR58","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41571-024-00924-9","volume":"21","author":"J Yoon","year":"2024","unstructured":"Yoon J, Oh DY. HER2-targeted therapies beyond breast cancer\u2014an update. Nat Rev Clin Oncol. 2024;21(9):675\u2013700. https:\/\/doi.org\/10.1038\/s41571-024-00924-9.","journal-title":"Nat Rev Clin Oncol"},{"key":"641_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100947","volume":"68","author":"R Du","year":"2023","unstructured":"Du R, Zhang X, Lu X, Ma X, Guo X, Shi C, et al. PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity. Drug Resist Updat. 2023;68:100947. https:\/\/doi.org\/10.1016\/j.drup.2023.100947.","journal-title":"Drug Resist Updat"},{"issue":"6","key":"641_CR60","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.7150\/ijbs.108803","volume":"21","author":"F Li","year":"2025","unstructured":"Li F, Gao C, Huang Y, Qiao Y, Xu H, Liu S, et al. Unraveling the breast cancer tumor microenvironment: crucial factors influencing natural killer cell function and therapeutic strategies. Int J Biol Sci. 2025;21(6):2606\u201328. https:\/\/doi.org\/10.7150\/ijbs.108803.","journal-title":"Int J Biol Sci"},{"issue":"10","key":"641_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.100977","volume":"14","author":"F Li","year":"2024","unstructured":"Li F, Shi Y, Ma M, Yang X, Chen X, Xie Y, et al. Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC. J Pharm Anal. 2024;14(10):100977. https:\/\/doi.org\/10.1016\/j.jpha.2024.100977.","journal-title":"J Pharm Anal"},{"issue":"1","key":"641_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00799-8","volume":"11","author":"A Sharma","year":"2025","unstructured":"Sharma A, Sudan SK, Vikramdeo KS, Khan MA, Tahir M, Carter JE, et al. Subtype- and race-specific variations in the immune landscape of breast cancer: therapeutic implications. NPJ Breast Cancer. 2025;11(1):78. https:\/\/doi.org\/10.1038\/s41523-025-00799-8.","journal-title":"NPJ Breast Cancer"},{"key":"641_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156226","volume":"275","author":"TM Martorana","year":"2025","unstructured":"Martorana TM, Ricciardi G, Tralongo P, Fiorentino V, Pizzimenti C, Franchina M, et al. Targeting the tumor microenvironment in triple-negative breast cancer: biological insights and therapeutic opportunities. Pathol Res Pract. 2025;275:156226. https:\/\/doi.org\/10.1016\/j.prp.2025.156226.","journal-title":"Pathol Res Pract"},{"key":"641_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1677363","volume":"16","author":"T Wu","year":"2025","unstructured":"Wu T, Liao Y. Roles of tumor-associated macrophages in triple-negative breast cancer progression. Front Immunol. 2025;16:1677363. https:\/\/doi.org\/10.3389\/fimmu.2025.1677363.","journal-title":"Front Immunol"},{"key":"641_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114988","volume":"161","author":"S Wang","year":"2025","unstructured":"Wang S, Wang Y, Bu Y, Duan X, Guo X, Wu W, et al. ISLR knockdown enhances radiotherapy-induced anti-tumor immunity by disrupting the Treg-mregDC-lymphoid niche in triple-negative breast cancer. Int Immunopharmacol. 2025;161:114988. https:\/\/doi.org\/10.1016\/j.intimp.2025.114988.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"641_CR66","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/path.6395","volume":"265","author":"X Lu","year":"2025","unstructured":"Lu X, Gou Z, Chen H, Li L, Chen F, Bao C, et al. Extracellular matrix cancer-associated fibroblasts promote stromal fibrosis and immune exclusion in triple-negative breast cancer. J Pathol. 2025;265(3):385\u201399. https:\/\/doi.org\/10.1002\/path.6395.","journal-title":"J Pathol"},{"key":"641_CR67","doi-asserted-by":"publisher","DOI":"10.34133\/research.0915","volume":"8","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li S, Wu Y, Yu X, Dai Y, Wang Y, et al. Gene signature-based drug screening reveals Ponatinib enhances immunotherapy efficacy in triple-negative breast cancer by reversing MDSC-mediated immunosuppressive tumor microenvironment. Research (Wash D C). 2025;8:0915. https:\/\/doi.org\/10.34133\/research.0915.","journal-title":"Research (Wash D C)"},{"issue":"1","key":"641_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07370-w","volume":"23","author":"Y Yang","year":"2025","unstructured":"Yang Y, Wang W. Recent progress in immune evasion mechanisms of triple-negative breast cancer. J Transl Med. 2025;23(1):1314. https:\/\/doi.org\/10.1186\/s12967-025-07370-w.","journal-title":"J Transl Med"},{"issue":"7","key":"641_CR69","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/procel\/pwaf011","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zong X, Altea-Manzano P, Fu J. Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities. Protein Cell. 2025;16(7):506\u201331. https:\/\/doi.org\/10.1093\/procel\/pwaf011.","journal-title":"Protein Cell"},{"issue":"3","key":"641_CR70","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41416-023-02322-x","volume":"129","author":"CM Vidal","year":"2023","unstructured":"Vidal CM, Ouyang C, Qi Y, Mendez-Dorantes C, Coblentz A, Alva-Ornelas JA, et al. Arginine regulates HSPA5\/BiP translation through ribosome pausing in triple-negative breast cancer cells. Br J Cancer. 2023;129(3):444\u201354. https:\/\/doi.org\/10.1038\/s41416-023-02322-x.","journal-title":"Br J Cancer"},{"key":"641_CR71","doi-asserted-by":"publisher","unstructured":"Morotti M, Zois CE, El-Ansari R, Craze ML, Rakha EA, Fan SJ, et al. Increased expression of glutamine transporter SNAT2\/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer. Br J Cancer. 2021;124(2):494\u2013505. https:\/\/doi.org\/10.1038\/s41416-020-01113-y","DOI":"10.1038\/s41416-020-01113-y"},{"issue":"1","key":"641_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02714-3","volume":"11","author":"Z Ge","year":"2025","unstructured":"Ge Z, Wallace M, Turner R, Yin M, Rooney MF, Porter RK. Metabolic interplay between exogenous cystine and glutamine dependence in triple-negative breast cancer. Cell Death Discov. 2025;11(1):430. https:\/\/doi.org\/10.1038\/s41420-025-02714-3.","journal-title":"Cell Death Discov"},{"key":"641_CR73","doi-asserted-by":"publisher","DOI":"10.1172\/jci140100","author":"DN Edwards","year":"2021","unstructured":"Edwards DN, Ngwa VM, Raybuck AL, Wang S, Hwang Y, Kim LC, et al. Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/jci140100.","journal-title":"J Clin Invest"},{"key":"641_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/cells15010025","author":"H Tishler","year":"2025","unstructured":"Tishler H, Ziman S, Cheng K, Wang K, Sanghvi N, Adler L, et al. Inhibition of tumor microenvironment-driven JAK-STAT signaling enhances response to arginine deprivation therapy in triple-negative breast cancer. Cells. 2025. https:\/\/doi.org\/10.3390\/cells15010025.","journal-title":"Cells"},{"issue":"9","key":"641_CR75","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid P, Cortes J, Pusztai L, McArthur H, K\u00fcmmel S, Bergh J, et al. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382(9):810\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1910549.","journal-title":"N Engl J Med"},{"issue":"2","key":"641_CR76","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.trecan.2024.11.011","volume":"11","author":"K Ma","year":"2025","unstructured":"Ma K, Wang L, Li W, Tang T, Ma B, Zhang L. Turning cold into hot: emerging strategies to fire up the tumor microenvironment. Trends Cancer. 2025;11(2):117\u201334. https:\/\/doi.org\/10.1016\/j.trecan.2024.11.011.","journal-title":"Trends Cancer"},{"issue":"13","key":"641_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137208","volume":"25","author":"L Yang","year":"2024","unstructured":"Yang L, Hu Q, Huang T. Breast cancer treatment strategies targeting the tumor microenvironment: how to convert \u201ccold\u201d tumors to \u201chot\u201d tumors. Int J Mol Sci. 2024;25(13):7208. https:\/\/doi.org\/10.3390\/ijms25137208.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"641_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu B, Zhang B, Li B, Wu H, Jiang M. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct Target Ther. 2024;9(1):274. https:\/\/doi.org\/10.1038\/s41392-024-01979-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"641_CR79","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ccell.2024.11.008","volume":"43","author":"Z Yang","year":"2025","unstructured":"Yang Z, Liu X, Zhu J, Chai Y, Cong B, Li B, et al. Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1. Cancer Cell. 2025;43(1):86-102.e10. https:\/\/doi.org\/10.1016\/j.ccell.2024.11.008.","journal-title":"Cancer Cell"},{"key":"641_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102454","volume":"59","author":"X Huang","year":"2025","unstructured":"Huang X, Yang W, Hu X, Peng L, Dong J, Li L. Pterostilbene induces pyroptosis in mouse breast cancer cells through the caspase-3\/Gasdermin E signaling pathway and reshapes the tumor immune microenvironment. Transl Oncol. 2025;59:102454. https:\/\/doi.org\/10.1016\/j.tranon.2025.102454.","journal-title":"Transl Oncol"},{"issue":"22","key":"641_CR81","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.2174\/1381612825666190709203239","volume":"25","author":"S Desai","year":"2019","unstructured":"Mangal S, Jana S, Dutta A, Kar R, Are V, Pradhan S, et al. Antiproliferative effect of Filopaludina bengalensis fluid inducing apoptosis-necroptosis synergy with immunogenic remodelling in triple-negative breast cancer. Sci Rep. 2025;15(1):41864.https:\/\/doi.org\/10.1038\/s41598-025-25810-x","journal-title":"Curr Pharm Des"},{"issue":"2","key":"641_CR82","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Buqu\u00e9 A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2017;17(2):97\u2013111. https:\/\/doi.org\/10.1038\/nri.2016.107.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"641_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-27173-9","volume":"15","author":"B Rahmani","year":"2025","unstructured":"Quan X, Kwak BS, Lee JY, Park JH, Lee A, Kim TH, et al. Cordyceps militaris Induces Immunogenic Cell Death and Enhances Antitumor Immunogenic Response in Breast Cancer. Evid Based Complement Alternat Med. 2020;2020:9053274.https:\/\/doi.org\/10.1155\/2020\/9053274","journal-title":"Sci Rep"},{"key":"641_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ph18040538","author":"A Panossian","year":"2025","unstructured":"Li X, Zheng J, Chen S, Meng FD, Ning J, Sun SL. Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK\/elF2\u03b1\/ATF4\/CHOP pathway in breast cancer. Cell Death Dis. 2021;12(4):314.https:\/\/doi.org\/10.1038\/s41419-021-03605-y","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"641_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04755-7","volume":"21","author":"Y Chen","year":"2023","unstructured":"Wen H, Zhong Y, Yin Y, Qin K, Yang L, Li D, et al. A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway. Int J Biol Sci. 2022;18(7):2898\u2013913.https:\/\/doi.org\/10.7150\/ijbs.70975","journal-title":"J Transl Med"},{"key":"641_CR86","doi-asserted-by":"publisher","DOI":"10.1007\/s13659-025-00589-6","author":"R Muthuraj","year":"2026","unstructured":"Zhong C, Li Y, Li W, Lian S, Li Y, Wu C, et al. Ganoderma lucidum extract promotes tumor cell pyroptosis and inhibits metastasis in breast cancer. Food Chem Toxicol. 2023;174:113654.https:\/\/doi.org\/10.1016\/j.fct.2023.113654","journal-title":"Nat Prod Bioprospect"},{"issue":"2","key":"641_CR87","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Qian D, Li J, Huang M, Cui Q, Liu X, Sun K. Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy. Biomed Pharmacother. 2023;162:114685.https:\/\/doi.org\/10.1016\/j.biopha.2023.114685 .","journal-title":"Nat Rev Clin Oncol"},{"key":"641_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.678865","volume":"12","author":"J Gao","year":"2021","unstructured":"Gao J, Zhang YN, Cui J, Zhang J, Ming Y, Hao Z, et al. A polysaccharide from the whole plant of Plantago asiatica L. enhances the antitumor activity of dendritic cell-based immunotherapy against breast cancer. Front Pharmacol. 2021;12:678865. https:\/\/doi.org\/10.3389\/fphar.2021.678865.","journal-title":"Front Pharmacol"},{"issue":"12","key":"641_CR89","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.annonc.2020.09.010","volume":"31","author":"F Cardoso","year":"2020","unstructured":"Jia G, Shao X, Zhao R, Zhang T, Zhou X, Yang Y, et al. Portulaca oleracea L. polysaccharides enhance the immune efficacy of dendritic cell vaccine for breast cancer. Food Funct. 2021;12(9):4046\u201359.https:\/\/doi.org\/10.1039\/d0fo02522d","journal-title":"Ann Oncol"},{"issue":"2","key":"641_CR90","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/17425247.2024.2317194","volume":"21","author":"J Ahmad","year":"2024","unstructured":"Zhang S, Pang G, Chen C, Qin J, Yu H, Liu Y, et al. Effective cancer immunotherapy by Ganoderma lucidum polysaccharide-gold nanocomposites through dendritic cell activation and memory T cell response. Carbohydr Polym. 2019;205:192\u2013202.https:\/\/doi.org\/10.1016\/j.carbpol.2018.10.028","journal-title":"Expert Opin Drug Deliv"},{"key":"641_CR91","doi-asserted-by":"publisher","first-page":"1369563","DOI":"10.3389\/fphar.2024.1369563","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang H, Zhan X, Zhao J, Shi W, Liu T, Wei Z, et al. Schisandrin C enhances type I IFN response activation to reduce tumor growth and sensitize chemotherapy through antitumor immunity. Front Pharmacol. 2024;15:1369563. https:\/\/doi.org\/10.3389\/fphar.2024.1369563.","journal-title":"Front Pharmacol"},{"key":"641_CR92","doi-asserted-by":"crossref","unstructured":"Xue P, Yu Z, Shang Y, Liu S, Zhang M, Zhu F, et al. Dual-targeted fucoidan-TPP nanoparticles delivery system potently inhibit breast cancer via mitochondrial dysfunction and cGAS-STING activation. Colloids Surf B Biointerfaces. 2026;258:115279.https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115279","DOI":"10.1016\/j.colsurfb.2025.115279"},{"key":"641_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.113978","volume":"274","author":"XX Deng","year":"2021","unstructured":"Deng XX, Jiao YN, Hao HF, Xue D, Bai CC, Han SY. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 \/ STAT3 \/ PD-L1 signaling pathways. J Ethnopharmacol. 2021;274:113978. https:\/\/doi.org\/10.1016\/j.jep.2021.113978.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"641_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58208-2","volume":"14","author":"S Nilkhet","year":"2024","unstructured":"Nilkhet S, Mongkolpobsin K, Sillapachaiyaporn C, Wongsirojkul N, Tencomnao T, Chuchawankul S. M1 macrophages polarized by crude polysaccharides isolated from Auricularia polytricha exhibit anti-tumor effect on human breast cancer cells. Sci Rep. 2024;14(1):8179. https:\/\/doi.org\/10.1038\/s41598-024-58208-2.","journal-title":"Sci Rep"},{"issue":"2","key":"641_CR95","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/0118715206275259231105184959","volume":"24","author":"B Deswal","year":"2024","unstructured":"Deswal B, Bagchi U, Kapoor S. Curcumin suppresses M2 macrophage-derived paclitaxel chemoresistance through inhibition of PI3K-AKT\/STAT3 signaling. Anticancer Agents Med Chem. 2024;24(2):146\u201356. https:\/\/doi.org\/10.2174\/0118715206275259231105184959.","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"641_CR96","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/08923973.2024.2425028","volume":"47","author":"A Chaudhary","year":"2025","unstructured":"Chaudhary A, Patil P, Raina P, Kaul-Ghanekar R. Matairesinol repolarizes M2 macrophages to M1 phenotype to induce apoptosis in triple-negative breast cancer cells. Immunopharmacol Immunotoxicol. 2025;47(1):8\u201322. https:\/\/doi.org\/10.1080\/08923973.2024.2425028.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"641_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154757","volume":"114","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Zhong X, Nie X, Gu H, Wu X, Li R, et al. Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1\/2 signaling. Phytomedicine. 2023;114:154757. https:\/\/doi.org\/10.1016\/j.phymed.2023.154757.","journal-title":"Phytomedicine"},{"key":"641_CR98","doi-asserted-by":"publisher","unstructured":"Guo Y, Lin X, Wang P, Wang Y, Chen M, Tang S, et al. Smilax china L. Rhizome extract enhances anti-tumor immune responses by resetting M2-like macrophages and tumor-associated macrophages to M1-like via ERK1\/2 signaling. J Ethnopharmacol. 2025;349:119983. https:\/\/doi.org\/10.1016\/j.jep.2025.119983","DOI":"10.1016\/j.jep.2025.119983"},{"issue":"Pt 1","key":"641_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129674","volume":"261","author":"MQ Liu","year":"2024","unstructured":"Liu MQ, Bao CJ, Liang XF, Ji XY, Zhao LQ, Yao AN, et al. Specific molecular weight of Lycium barbarum polysaccharide for robust breast cancer regression by repolarizing tumor-associated macrophages. Int J Biol Macromol. 2024;261(Pt 1):129674. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129674.","journal-title":"Int J Biol Macromol"},{"key":"641_CR100","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15:123\u201347. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012718.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"641_CR101","doi-asserted-by":"publisher","DOI":"10.1007\/s13659-024-00431-5","volume":"14","author":"GA Cordell","year":"2024","unstructured":"Xu J, Ding L, Mei J, Hu Y, Kong X, Dai S, et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct Target Ther. 2025;10(1):268.https:\/\/doi.org\/10.1038\/s41392-025-02325-5","journal-title":"Nat Prod Bioprospect"},{"key":"641_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184509","author":"D Delmas","year":"2021","unstructured":"Delmas D, Hermetet F, Aires V. PD-1\/PD-L1 checkpoints and resveratrol: a controversial new way for a therapeutic strategy. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13184509.","journal-title":"Cancers (Basel)"},{"key":"641_CR103","doi-asserted-by":"publisher","unstructured":"Li X, Ruan Q, Yang W, Tian H, Wu N, Qadir J, et al. Polysaccharide isolated from Grifola frondosa eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T cells responses. Int J Biol Sci. 2024;20(2):664\u201379. https:\/\/doi.org\/10.7150\/ijbs.85276","DOI":"10.7150\/ijbs.85276"},{"issue":"Pt 1","key":"641_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131949","volume":"270","author":"Y Bu","year":"2024","unstructured":"Bu Y, Liu Q, Shang Y, Zhao Z, Sun H, Chen F, et al. Ganoderma lucidum spores-derived particulate \u03b2-glucan treatment improves antitumor response by regulating myeloid-derived suppressor cells in triple-negative breast cancer. Int J Biol Macromol. 2024;270(Pt 1):131949. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131949.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"641_CR105","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/08830185.2020.1845670","volume":"40","author":"E Arianfar","year":"2021","unstructured":"Arianfar E, Shahgordi S, Memarian A. Natural Killer cell defects in breast cancer: a key pathway for tumor evasion. Int Rev Immunol. 2021;40(3):197\u2013216. https:\/\/doi.org\/10.1080\/08830185.2020.1845670.","journal-title":"Int Rev Immunol"},{"key":"641_CR106","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.molimm.2021.03.003","volume":"136","author":"S Rezaeifard","year":"2021","unstructured":"Rezaeifard S, Talei A, Shariat M, Erfani N. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer. Mol Immunol. 2021;136:161\u20137. https:\/\/doi.org\/10.1016\/j.molimm.2021.03.003.","journal-title":"Mol Immunol"},{"issue":"1","key":"641_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56420-w","volume":"16","author":"S Lee","year":"2025","unstructured":"Lee S, Ricci B, Tran J, Eul E, Ye J, Ren Q, et al. Stroma-derived Dickkopf-1 contributes to the suppression of NK cell cytotoxicity in breast cancer. Nat Commun. 2025;16(1):1183. https:\/\/doi.org\/10.1038\/s41467-025-56420-w.","journal-title":"Nat Commun"},{"key":"641_CR108","doi-asserted-by":"publisher","unstructured":"Yang C, Qian C, Zhang T, Zheng W, Zhang S, Wang S, et al. The killing effect of Tanshinol on breast cancer cells: insight into the reversion of TGF-\u03b21-mediated suppression of NK cell functions. Front Biosci (Landmark Ed). 2021;26(11):1106\u201318. https:\/\/doi.org\/10.52586\/5013","DOI":"10.52586\/5013"},{"issue":"4","key":"641_CR109","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1248\/bpb.b23-00802","volume":"47","author":"Y Masuda","year":"2024","unstructured":"Masuda Y, Yamashita S, Nakayama Y, Shimizu R, Konishi M. Maitake beta-glucan enhances the therapeutic effect of Trastuzumab via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. Biol Pharm Bull. 2024;47(4):840\u20137. https:\/\/doi.org\/10.1248\/bpb.b23-00802.","journal-title":"Biol Pharm Bull"},{"issue":"11","key":"641_CR110","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1089\/jmf.2025.k.0032","volume":"28","author":"NB Nam","year":"2025","unstructured":"Nam NB, Ko YS, Won JY, Nsanzimana V, Yun SP, Park SW, et al. Anticancer effects of the polysaccharide fraction of bioprocessed black rice bran extract in triple-negative breast cancer (TNBC) cells and radiotherapy-resistant TNBC cells by inhibiting interactions with endothelial cells and inducing natural killer cell activity. J Med Food. 2025;28(11):1101\u20139. https:\/\/doi.org\/10.1089\/jmf.2025.k.0032.","journal-title":"J Med Food"},{"key":"641_CR111","doi-asserted-by":"publisher","unstructured":"Khalaf TK, Ismail N, Nazri NA, Ahmed N, Yajid AI, Mohamud R, et al. Pereskia bleo augments NK cell cytotoxicity against triple-negative breast cancer cells (MDA-MB-231). PeerJ. 2024;12:e18420. https:\/\/doi.org\/10.7717\/peerj.18420","DOI":"10.7717\/peerj.18420"},{"key":"641_CR112","doi-asserted-by":"publisher","unstructured":"Lv J, Liu Z, Ren X, Song S, Zhang Y, Wang Y. \u03b3\u03b4T cells, a key subset of T cell for cancer immunotherapy. Front Immunol. 2025;16:1562188. https:\/\/doi.org\/10.3389\/fimmu.2025.1562188","DOI":"10.3389\/fimmu.2025.1562188"},{"key":"641_CR113","doi-asserted-by":"publisher","unstructured":"Silva-Romeiro S, S\u00e1nchez-Le\u00f3n ML, Jim\u00e9nez-Cortegana C, de Toro-Salas R, Machuca Aguado J, S\u00e1nchez-Margalet V, et al. Gamma-delta T cells in breast cancer: dual role in tumor immunity and emerging therapeutic approaches. Int Rev Cell Mol Biol. 2025;398:185\u2013207. https:\/\/doi.org\/10.1016\/bs.ircmb.2025.08.013","DOI":"10.1016\/bs.ircmb.2025.08.013"},{"key":"641_CR114","doi-asserted-by":"publisher","unstructured":"Wu Y, Kyle-Cezar F, Woolf RT, Naceur-Lombardelli C, Owen J, Biswas D, et al. An innate-like V\u03b41(+) \u03b3\u03b4 T cell compartment in the human breast is associated with remission in triple-negative breast cancer. Sci Transl Med. 2019;11(513). https:\/\/doi.org\/10.1126\/scitranslmed.aax9364","DOI":"10.1126\/scitranslmed.aax9364"},{"key":"641_CR115","doi-asserted-by":"publisher","unstructured":"Janssen A, Villacorta Hidalgo J, Beringer DX, van Dooremalen S, Fernando F, van Diest E, et al. \u03b3\u03b4 T-cell Receptors derived from breast cancer-infiltrating T lymphocytes mediate antitumor reactivity. Cancer Immunol Res. 2020;8(4):530\u201343. https:\/\/doi.org\/10.1158\/2326-6066.Cir-19-0513","DOI":"10.1158\/2326-6066.Cir-19-0513"},{"key":"641_CR116","doi-asserted-by":"publisher","unstructured":"Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, et al. IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 2015;522(7556):345\u20138. https:\/\/doi.org\/10.1038\/nature14282","DOI":"10.1038\/nature14282"},{"key":"641_CR117","doi-asserted-by":"publisher","unstructured":"Zhang Z, Yang C, Li L, Zhu Y, Su K, Zhai L, et al. \"\u03b3\u03b4T Cell-IL17A-Neutrophil\" axis drives immunosuppression and confers breast cancer resistance to high-dose anti-VEGFR2 therapy. Front Immunol. 2021;12:699478. https:\/\/doi.org\/10.3389\/fimmu.2021.699478","DOI":"10.3389\/fimmu.2021.699478"},{"key":"641_CR118","doi-asserted-by":"publisher","unstructured":"Hu G, Cheng P, Pan J, Wang S, Ding Q, Jiang Z, et al. An IL6-adenosine positive feedback loop between CD73(+) \u03b3\u03b4Tregs and CAFs promotes tumor progression in human breast cancer. Cancer Immunol Res. 2020;8(10):1273\u201386.https:\/\/doi.org\/10.1158\/2326-6066.Cir-19-0923","DOI":"10.1158\/2326-6066.Cir-19-0923"},{"key":"641_CR119","doi-asserted-by":"publisher","unstructured":"Zhang Y, Xiang Z, Xu Y, Cheung LS, Wang X, Wang M, et al. Oleic acid restores the impaired antitumor immunity of \u03b3\u03b4-T cells induced by palmitic acid. Signal Transduct Target Ther. 2025;10(1):209. https:\/\/doi.org\/10.1038\/s41392-025-02295-8","DOI":"10.1038\/s41392-025-02295-8"},{"key":"641_CR120","doi-asserted-by":"publisher","unstructured":"Qiu D, Yan X, Xiao X, Zhang G, Wang Y, Cao J, et al. To explore immune synergistic function of Quercetin in inhibiting breast cancer cells. Cancer Cell Int. 2021;21(1):632. https:\/\/doi.org\/10.1186\/s12935-021-02345-5","DOI":"10.1186\/s12935-021-02345-5"},{"key":"641_CR121","doi-asserted-by":"publisher","unstructured":"Tiwari H, Singh S, Sharma S, Gupta P, Verma A, Chattopadhaya A, et al. Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities. Med Res Rev. 2025;45(3):817\u201341. https:\/\/doi.org\/10.1002\/med.22090","DOI":"10.1002\/med.22090"},{"key":"641_CR122","doi-asserted-by":"publisher","unstructured":"Koorman T, Jansen KA, Khalil A, Haughton PD, Visser D, R\u00e4tze MAK, et al. Spatial collagen stiffening promotes collective breast cancer cell invasion by reinforcing extracellular matrix alignment. Oncogene. 2022;41(17):2458\u201369. https:\/\/doi.org\/10.1038\/s41388-022-02258-1","DOI":"10.1038\/s41388-022-02258-1"},{"key":"641_CR123","doi-asserted-by":"publisher","unstructured":"Moro M, Balestrero FC, Colombo G, Torretta S, Clemente N, Ciccone V, et al. Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) drives abnormal pericyte-rich vasculature in triple-negative breast cancer. Angiogenesis. 2024;28(1):4. https:\/\/doi.org\/10.1007\/s10456-024-09956-2","DOI":"10.1007\/s10456-024-09956-2"},{"key":"641_CR124","doi-asserted-by":"publisher","unstructured":"Offeddu GS, Cambria E, Shelton SE, Haase K, Wan Z, Possenti L, et al. Personalized vascularized models of breast cancer desmoplasia reveal biomechanical determinants of drug delivery to the tumor. Adv Sci (Weinh). 2024;11(38):e2402757. https:\/\/doi.org\/10.1002\/advs.202402757","DOI":"10.1002\/advs.202402757"},{"key":"641_CR125","doi-asserted-by":"publisher","unstructured":"Cayetano-Salazar L, Nava-Tapia DA, Astudillo-Justo KD, Arizmendi-Izazaga A, Sotelo-Leyva C, Herrera-Martinez M, et al. Flavonoids as regulators of TIMPs expression in cancer: consequences, opportunities, and challenges. Life Sci. 2022;308:120932. https:\/\/doi.org\/10.1016\/j.lfs.2022.120932","DOI":"10.1016\/j.lfs.2022.120932"},{"issue":"20","key":"641_CR126","volume":"29","author":"L Wu","year":"2025","unstructured":"Wu L, Wang Z, Tan X, Wu Y, Zheng Y. Effect of extracellular matrix stiffness on tumor progression and treatment strategies. Zhongguo Zu Zhi Gong Cheng Yan Jiu. 2025;29(20):4286.","journal-title":"Zhongguo Zu Zhi Gong Cheng Yan Jiu"},{"key":"641_CR127","doi-asserted-by":"publisher","unstructured":"Li Y, Liang X, Shen C, Deng K, Zeng Z, Guo B, et al. Bio-responsive macromolecular drug and small-molecular drug conjugates: nanoparticulate prodrugs for tumor microenvironment heterogeneity management and therapeutic response enhancement. Small. 2023;19(39):e2301656. https:\/\/doi.org\/10.1002\/smll.202301656","DOI":"10.1002\/smll.202301656"},{"key":"641_CR128","doi-asserted-by":"publisher","unstructured":"Cao L, Li Z, Song J, Xia X, Zhang G, Wang H, et al. Sequential drug release system: targeting the tumor ECM for enhanced chemotherapy efficacy. Proc Natl Acad Sci USA. 2025;122(23):e2421061122. https:\/\/doi.org\/10.1073\/pnas.2421061122","DOI":"10.1073\/pnas.2421061122"},{"key":"641_CR129","doi-asserted-by":"publisher","unstructured":"Zuo R, Guo X, Song X, Gao X, Zhang J, Jiang S, et al. New uses of halofuginone to treat cancer. J Pharm Anal. 2025;15(3):101080. https:\/\/doi.org\/10.1016\/j.jpha.2024.101080","DOI":"10.1016\/j.jpha.2024.101080"},{"key":"641_CR130","doi-asserted-by":"publisher","unstructured":"Zhu J, Liu S, Liu P, Zhai K, Liu H. Traditional medicine meets modern science: Halofuginone's role in combating autoimmune diseases. J Nat Med. 2025;79(5):1017\u201329. https:\/\/doi.org\/10.1007\/s11418-025-01927-1","DOI":"10.1007\/s11418-025-01927-1"},{"issue":"11","key":"641_CR131","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3760\/cma.j.cn12152-20221108-00747","volume":"45","author":"J Zhang","year":"2023","unstructured":"Zhang J, Li Y, Tang YX, Wu FY, Wang SJ. [Remodeling of tumor stroma combined with photothermal therapy in the treatment of triple-negative breast cancer]. Zhonghua Zhong Liu Za Zhi. 2023;45(11):926\u201333. https:\/\/doi.org\/10.3760\/cma.j.cn12152-20221108-00747.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"1","key":"641_CR132","doi-asserted-by":"publisher","DOI":"10.5812\/ijpr-165301","volume":"24","author":"Y Xue","year":"2025","unstructured":"Xue Y, Wang M. Isoliquiritigenin in breast cancer: a systematic review of its preventive and anti-metastatic mechanisms. Iran J Pharm Res. 2025;24(1):e165301. https:\/\/doi.org\/10.5812\/ijpr-165301.","journal-title":"Iran J Pharm Res"},{"issue":"8","key":"641_CR133","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1002\/ptr.6647","volume":"34","author":"M Imran","year":"2020","unstructured":"Imran M, Aslam Gondal T, Atif M, Shahbaz M, Batool Qaisarani T, Hanif Mughal M, et al. Apigenin as an anticancer agent. Phytother Res. 2020;34(8):1812\u201328. https:\/\/doi.org\/10.1002\/ptr.6647.","journal-title":"Phytother Res"},{"issue":"1","key":"641_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-20757-5","volume":"15","author":"N Masarkar","year":"2025","unstructured":"Masarkar N, Pal M, Bisai A, Yadav AK, Roy M, Ray SK, et al. Pharmacokinetic, docking, and DFT analyses reveal Moringa oleifera phytochemicals as inhibitors of HIF-1\u03b1\/VEGF\/GLUT1 signaling pathway in breast cancer. Sci Rep. 2025;15(1):36837. https:\/\/doi.org\/10.1038\/s41598-025-20757-5.","journal-title":"Sci Rep"},{"key":"641_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153503","volume":"84","author":"Q Su","year":"2021","unstructured":"Su Q, Wang J, Wu Q, Ullah A, Ghauri MA, Sarwar A, et al. Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1\u03b1 pathways in breast cancer. Phytomedicine. 2021;84:153503. https:\/\/doi.org\/10.1016\/j.phymed.2021.153503.","journal-title":"Phytomedicine"},{"issue":"6","key":"641_CR136","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1111\/jcmm.15056","volume":"24","author":"Q Su","year":"2020","unstructured":"Su Q, Wang J, Fan M, Ghauri MA, Ullah A, Wang B, et al. Sanguinarine disrupts the colocalization and interaction of HIF-1\u03b1 with tyrosine and serine phosphorylated-STAT3 in breast cancer. J Cell Mol Med. 2020;24(6):3756\u201361. https:\/\/doi.org\/10.1111\/jcmm.15056.","journal-title":"J Cell Mol Med"},{"issue":"17","key":"641_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175716","volume":"27","author":"S Jampasri","year":"2022","unstructured":"Jampasri S, Reabroi S, Tungmunnithum D, Parichatikanond W, Pinthong D. Plumbagin suppresses breast cancer progression by downregulating HIF-1\u03b1 expression via a PI3K\/Akt\/mTOR independent pathway under hypoxic condition. Molecules. 2022;27(17):5716. https:\/\/doi.org\/10.3390\/molecules27175716.","journal-title":"Molecules"},{"issue":"1","key":"641_CR138","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/01635581.2024.2401647","volume":"77","author":"N Akla","year":"2025","unstructured":"Akla N, Veilleux C, Annabi B. The chemopreventive impact of diet-derived phytochemicals on the adipose tissue and breast tumor microenvironment secretome. Nutr Cancer. 2025;77(1):9\u201325. https:\/\/doi.org\/10.1080\/01635581.2024.2401647.","journal-title":"Nutr Cancer"},{"key":"641_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113319","volume":"153","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, Xu T, Liu Z, Tian W, Jiang ZH, Zhu GY, et al. Cryptolepine suppresses breast adenocarcinoma via inhibition of HIF-1 mediated glycolysis. Biomed Pharmacother. 2022;153:113319. https:\/\/doi.org\/10.1016\/j.biopha.2022.113319.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"641_CR140","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00204-023-03456-w","volume":"97","author":"HL Yang","year":"2023","unstructured":"Yang HL, Lin PY, Vadivalagan C, Lin YA, Lin KY, Hseu YC. Coenzyme Q(0) defeats NLRP3-mediated inflammation, EMT\/metastasis, and Warburg effects by inhibiting HIF-1\u03b1 expression in human triple-negative breast cancer cells. Arch Toxicol. 2023;97(4):1047\u201368. https:\/\/doi.org\/10.1007\/s00204-023-03456-w.","journal-title":"Arch Toxicol"},{"key":"641_CR141","doi-asserted-by":"publisher","first-page":"8629","DOI":"10.2147\/ott.S239134","volume":"13","author":"J Zhou","year":"2020","unstructured":"Zhou J, Su CM, Chen HA, Du S, Li CW, Wu H, et al. Cryptanshinone inhibits the glycolysis and inhibits cell migration through PKM2\/\u03b2-Catenin axis in breast cancer. Onco Targets Ther. 2020;13:8629\u201339. https:\/\/doi.org\/10.2147\/ott.S239134.","journal-title":"Onco Targets Ther"},{"key":"641_CR142","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.freeradbiomed.2019.10.413","volume":"146","author":"Y Guo","year":"2020","unstructured":"Guo Y, Wei L, Zhou Y, Lu N, Tang X, Li Z, et al. Flavonoid GL-V9 induces apoptosis and inhibits glycolysis of breast cancer via disrupting GSK-3\u03b2-modulated mitochondrial binding of HKII. Free Radic Biol Med. 2020;146:119\u201329. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.10.413.","journal-title":"Free Radic Biol Med"},{"key":"641_CR143","doi-asserted-by":"publisher","unstructured":"Monteiro F, Vittal Shetty V, Acharaya R, Naresh S, Munikumar M, S Shetty S, et al. Naringin from citrus maxima peel: a potential therapeutic agent for breast cancer via PKM2 inhibition. Beni-Suef Univ J Basic Appl Sci. 2025;14(1). https:\/\/doi.org\/10.1186\/s43088-025-00668-0","DOI":"10.1186\/s43088-025-00668-0"},{"key":"641_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157323","volume":"148","author":"CL Dai","year":"2025","unstructured":"Dai CL, Qiu ZY, Guo X, Yan S, Wang AQ, Zhao J, et al. Dual targeting of lipogenesis and PUFAs homeostasis by compound kushen injection suppresses breast cancer bone metastasis. Phytomedicine. 2025;148:157323. https:\/\/doi.org\/10.1016\/j.phymed.2025.157323.","journal-title":"Phytomedicine"},{"key":"641_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249575","author":"YJ Lee","year":"2020","unstructured":"Lee YJ, Kim J. Resveratrol activates natural killer cells through Akt- and mTORC2-mediated c-Myb upregulation. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21249575.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"641_CR146","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1016\/j.apsb.2023.05.006","volume":"13","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhang Z, Huang Z, Li M, Yang F, Wu Z, et al. Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-\u03b2-induced epithelial-mesenchymal transition via directly targeting TGF\u03b2R1. Acta Pharm Sin B. 2023;13(7):2990\u20133007. https:\/\/doi.org\/10.1016\/j.apsb.2023.05.006.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"641_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-021-01488-7","volume":"23","author":"M Zhang","year":"2021","unstructured":"Zhang M, Meng M, Liu Y, Qi J, Zhao Z, Qiao Y, et al. Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins. Breast Cancer Res. 2021;23(1):116. https:\/\/doi.org\/10.1186\/s13058-021-01488-7.","journal-title":"Breast Cancer Res"},{"issue":"11","key":"641_CR148","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1111\/cas.14648","volume":"111","author":"L Song","year":"2020","unstructured":"Song L, Chen X, Mi L, Liu C, Zhu S, Yang T, et al. Icariin-induced inhibition of SIRT6\/NF-\u03baB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer. Cancer Sci. 2020;111(11):4242\u201356. https:\/\/doi.org\/10.1111\/cas.14648.","journal-title":"Cancer Sci"},{"key":"641_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28041611","author":"P Liu","year":"2023","unstructured":"Liu P, Liu Y, Chen L, Fan Z, Luo Y, Cui Y. Anemoside A3 inhibits macrophage M2-like polarization to prevent triple-negative breast cancer metastasis. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28041611.","journal-title":"Molecules"},{"key":"641_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115755","volume":"432","author":"L Yin","year":"2021","unstructured":"Yin L, Fan Z, Liu P, Chen L, Guan Z, Liu Y, et al. Anemoside A3 activates TLR4-dependent M1-phenotype macrophage polarization to represses breast tumor growth and angiogenesis. Toxicol Appl Pharmacol. 2021;432:115755. https:\/\/doi.org\/10.1016\/j.taap.2021.115755.","journal-title":"Toxicol Appl Pharmacol"},{"key":"641_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115326","volume":"293","author":"Y Shi","year":"2022","unstructured":"Shi Y, Wu Y, Li F, Zhang Y, Hua C, Yang J, et al. Identifying the anti-metastasis effect of anhydroicaritin on breast cancer: coupling network pharmacology with experimental validation. J Ethnopharmacol. 2022;293:115326. https:\/\/doi.org\/10.1016\/j.jep.2022.115326.","journal-title":"J Ethnopharmacol"},{"key":"641_CR152","doi-asserted-by":"publisher","unstructured":"Sun Y, Zhou Q, Chen F, Gao X, Yang L, Jin X, et al. Berberine inhibits breast carcinoma proliferation and metastasis under hypoxic microenvironment involving gut microbiota and endogenous metabolites. Pharmacol Res. 2023;193:106817. https:\/\/doi.org\/10.1016\/j.phrs.2023.106817","DOI":"10.1016\/j.phrs.2023.106817"},{"key":"641_CR153","doi-asserted-by":"publisher","unstructured":"Zhao X, Liu J, Ge S, Chen C, Li S, Wu X, et al. Saikosaponin A Inhibits breast cancer by regulating Th1\/Th2 balance. Front Pharmacol. 2019;10:624.https:\/\/doi.org\/10.3389\/fphar.2019.00624","DOI":"10.3389\/fphar.2019.00624"},{"key":"641_CR154","doi-asserted-by":"publisher","unstructured":"Cao Y, Feng YH, Gao LW, Li XY, Jin QX, Wang YY, et al. Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo. Int Immunopharmacol. 2019;70:110\u20136. https:\/\/doi.org\/10.1016\/j.intimp.2019.01.041","DOI":"10.1016\/j.intimp.2019.01.041"},{"key":"641_CR155","doi-asserted-by":"publisher","unstructured":"Yao Y, Guo Q, Cao Y, Qiu Y, Tan R, Yu Z, et al. Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-\u03b2 signaling in breast cancer. J Exp Clin Cancer Res. 2018;37(1):282. https:\/\/doi.org\/10.1186\/s13046-018-0960-7","DOI":"10.1186\/s13046-018-0960-7"},{"key":"641_CR156","doi-asserted-by":"publisher","unstructured":"Yang C, Qian C, Zheng W, Dong G, Zhang S, Wang F, et al. Ginsenoside Rh2 enhances immune surveillance of natural killer (NK) cells via inhibition of ERp5 in breast cancer. Phytomedicine. 2024;123:155180. https:\/\/doi.org\/10.1016\/j.phymed.2023.155180","DOI":"10.1016\/j.phymed.2023.155180"},{"key":"641_CR157","doi-asserted-by":"publisher","unstructured":"Pu Y, Liu Z, Zhong C, Zhang X, Bao Y. Immunomodulatory effects of a polysaccharide from Solanum nigrum Linne through TLR4-MyD88 signaling pathway. Int Immunopharmacol. 2020;88:106973. https:\/\/doi.org\/10.1016\/j.intimp.2020.106973","DOI":"10.1016\/j.intimp.2020.106973"},{"key":"641_CR158","doi-asserted-by":"publisher","unstructured":"Zhang M, Liu J, Wang Y, Wang P, Morris-Natschke S, Lee KH. Molecular hybridization used to design and synthesize neo-tanshinlactone derivatives as PD-1\/PD-L1 inhibitors. Bioorg Med Chem. 2022;54:116579. https:\/\/doi.org\/10.1016\/j.bmc.2021.116579","DOI":"10.1016\/j.bmc.2021.116579"},{"key":"641_CR159","doi-asserted-by":"publisher","unstructured":"Amador-Mart\u00ednez D, Flores M, Vargas-Castro R, Garc\u00eda-Becerra R, Avila E, D\u00edaz L, et al. Exploring the antineoplastic potential of \u03b1-mangostin in breast cancer. Nat Prod Bioprospect. 2025;15(1):43. https:\/\/doi.org\/10.1007\/s13659-025-00528-5","DOI":"10.1007\/s13659-025-00528-5"},{"key":"641_CR160","doi-asserted-by":"publisher","unstructured":"Ye Y, Xie Y, Pei L, Jiang Z, Wu C, Liu S. Platycodin D induces neutrophil apoptosis by downregulating PD-L1 expression to inhibit breast cancer pulmonary metastasis. Int Immunopharmacol. 2023;115:109733. https:\/\/doi.org\/10.1016\/j.intimp.2023.109733","DOI":"10.1016\/j.intimp.2023.109733"},{"key":"641_CR161","doi-asserted-by":"publisher","unstructured":"Bi S, Jing Y, Cui X, Gong Y, Zhang J, Feng X, et al. A novel polysaccharide isolated from Coriolus versicolor polarizes M2 macrophages into an M1 phenotype and reversesits immunosuppressive effect on tumor microenvironment. Int J Biol Macromol. 2024;259(Pt 2):129352. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129352","DOI":"10.1016\/j.ijbiomac.2024.129352"},{"key":"641_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111338","volume":"137","author":"Y Xie","year":"2021","unstructured":"Xie Y, Jiang Z, Yang R, Ye Y, Pei L, Xiong S, et al. Polysaccharide-rich extract from Polygonatum sibiricum protects hematopoiesis in bone marrow suppressed by triple negative breast cancer. Biomed Pharmacother. 2021;137:111338. https:\/\/doi.org\/10.1016\/j.biopha.2021.111338.","journal-title":"Biomed Pharmacother"},{"key":"641_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315180","author":"H Zhao","year":"2022","unstructured":"Zhao H, Liang Y, Sun C, Zhai Y, Li X, Jiang M, et al. Dihydrotanshinone I inhibits the lung metastasis of breast cancer by suppressing neutrophil extracellular traps formation. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232315180.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"641_CR164","doi-asserted-by":"publisher","DOI":"10.1007\/s13659-025-00543-6","volume":"15","author":"Y Wu","year":"2025","unstructured":"Wu Y, Cui J, Chen L, Chen J, Huang J, Yang C, et al. Senkyunolide H reverses depression-induced breast cancer progression by regulating CXCR2. Nat Prod Bioprospect. 2025;15(1):57. https:\/\/doi.org\/10.1007\/s13659-025-00543-6.","journal-title":"Nat Prod Bioprospect"},{"key":"641_CR165","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.omto.2022.06.008","volume":"26","author":"JH Yen","year":"2022","unstructured":"Yen JH, Huang WC, Lin SC, Huang YW, Chio WT, Tsay GJ, et al. Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of cryptotanshinone by regulating TRAF6-ASK1 axis. Mol Ther Oncolytics. 2022;26:158\u201374. https:\/\/doi.org\/10.1016\/j.omto.2022.06.008.","journal-title":"Mol Ther Oncolytics"},{"key":"641_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.918975","volume":"13","author":"Y Guo","year":"2022","unstructured":"Guo Y, Mao W, Jin L, Xia L, Huang J, Liu X, et al. Flavonoid group of Smilax glabra Roxb. regulates the anti-tumor immune response through the STAT3\/HIF-1 signaling pathway. Front Pharmacol. 2022;13:918975. https:\/\/doi.org\/10.3389\/fphar.2022.918975.","journal-title":"Front Pharmacol"},{"key":"641_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117158","volume":"178","author":"C Xie","year":"2024","unstructured":"Xie C, Chan L, Pang Y, Shang Y, Cao W, Tuohan M, et al. Caffeic acid inhibits the tumorigenicity of triple-negative breast cancer cells through the FOXO1\/FIS pathway. Biomed Pharmacother. 2024;178:117158. https:\/\/doi.org\/10.1016\/j.biopha.2024.117158.","journal-title":"Biomed Pharmacother"},{"key":"641_CR168","doi-asserted-by":"publisher","unstructured":"Pan J, Jiang Z, Wu D, Yang C, Wang Z, Huang J. Huaier extractum promotes dendritic cells maturation and favors them to induce th1 immune response: one of the mechanisms underlying its anti-tumor activity. Integr Cancer Ther. 2020;19:1534735420946830. https:\/\/doi.org\/10.1177\/1534735420946830","DOI":"10.1177\/1534735420946830"},{"key":"641_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110380","volume":"129","author":"S Tian","year":"2020","unstructured":"Tian S, Song X, Wang Y, Wang X, Mou Y, Chen Q, et al. Chinese herbal medicine Baoyuan Jiedu decoction inhibits the accumulation of myeloid derived suppressor cells in pre-metastatic niche of lung via TGF-\u03b2\/CCL9 pathway. Biomed Pharmacother. 2020;129:110380. https:\/\/doi.org\/10.1016\/j.biopha.2020.110380.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"641_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29903","volume":"10","author":"L Chen","year":"2024","unstructured":"Chen L, Wei W, Sun J, Sun B, Deng R. Cordycepin enhances anti-tumor immunity in breast cancer by enhanceing ALB expression. Heliyon. 2024;10(9):e29903. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29903.","journal-title":"Heliyon"},{"issue":"1","key":"641_CR171","doi-asserted-by":"publisher","DOI":"10.1007\/s13659-025-00534-7","volume":"15","author":"H Zhao","year":"2025","unstructured":"Zhao H, Wang Y, Liu Z, Lin L, Xiang J, Zhu Z, et al. Synthesis and biological activity study of tanshinone I-pyridinium salt derivatives. Nat Prod Bioprospect. 2025;15(1):51. https:\/\/doi.org\/10.1007\/s13659-025-00534-7.","journal-title":"Nat Prod Bioprospect"},{"key":"641_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065542","author":"J Peng","year":"2023","unstructured":"Peng J, Yang Z, Li H, Hao B, Cui D, Shang R, et al. Quercetin reprograms immunometabolism of macrophages via the SIRT1\/PGC-1\u03b1 signaling pathway to ameliorate lipopolysaccharide-induced oxidative damage. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24065542.","journal-title":"Int J Mol Sci"},{"key":"641_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153437","volume":"81","author":"HT Wu","year":"2021","unstructured":"Wu HT, Lin J, Liu YE, Chen HF, Hsu KW, Lin SH, et al. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT\/mTOR signaling pathway. Phytomedicine. 2021;81:153437. https:\/\/doi.org\/10.1016\/j.phymed.2020.153437.","journal-title":"Phytomedicine"},{"key":"641_CR174","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejphar.2016.03.063","volume":"781","author":"X Zhao","year":"2016","unstructured":"Zhao X, Wang Q, Yang S, Chen C, Li X, Liu J, et al. Quercetin inhibits angiogenesis by targeting calcineurin in the xenograft model of human breast cancer. Eur J Pharmacol. 2016;781:60\u20138. https:\/\/doi.org\/10.1016\/j.ejphar.2016.03.063.","journal-title":"Eur J Pharmacol"},{"key":"641_CR175","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26061506","author":"N Gonzalez Suarez","year":"2021","unstructured":"Gonzalez Suarez N, Rodriguez Torres S, Ouanouki A, El Cheikh-Hussein L, Annabi B. EGCG inhibits adipose-derived mesenchymal stem cells differentiation into adipocytes and prevents a STAT3-mediated paracrine oncogenic control of triple-negative breast cancer cell invasive phenotype. Molecules. 2021. https:\/\/doi.org\/10.3390\/molecules26061506.","journal-title":"Molecules"},{"issue":"11","key":"641_CR176","doi-asserted-by":"publisher","first-page":"5682","DOI":"10.1039\/c8fo01397g","volume":"9","author":"R Wei","year":"2018","unstructured":"Wei R, Mao L, Xu P, Zheng X, Hackman RM, Mackenzie GG, et al. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models. Food Funct. 2018;9(11):5682\u201396. https:\/\/doi.org\/10.1039\/c8fo01397g.","journal-title":"Food Funct"},{"key":"641_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1331641","volume":"15","author":"D Li","year":"2024","unstructured":"Li D, Cao D, Sun Y, Cui Y, Zhang Y, Jiang J, et al. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy. Front Immunol. 2024;15:1331641. https:\/\/doi.org\/10.3389\/fimmu.2024.1331641.","journal-title":"Front Immunol"},{"key":"641_CR178","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010366","author":"WL Liao","year":"2022","unstructured":"Liao WL, Liu YF, Ying TH, Shieh JC, Hung YT, Lee HJ, et al. Inhibitory effects of ursolic acid on the stemness and progression of human breast cancer cells by modulating Argonaute-2. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms24010366.","journal-title":"Int J Mol Sci"},{"key":"641_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116269","volume":"172","author":"J Li","year":"2024","unstructured":"Li J, Liu Z, Wu X, Lee SM, Seto SW, Zhang J, et al. Anti-metastatic effects of AGS-30 on breast cancer through the inhibition of M2-like macrophage polarization. Biomed Pharmacother. 2024;172:116269. https:\/\/doi.org\/10.1016\/j.biopha.2024.116269.","journal-title":"Biomed Pharmacother"},{"key":"641_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115327","volume":"206","author":"YJ Chou","year":"2022","unstructured":"Chou YJ, Lin CC, Hsu YC, Syu JL, Tseng LM, Chiu JH, et al. Andrographolide suppresses the malignancy of triple-negative breast cancer by reducing THOC1-promoted cancer stem cell characteristics. Biochem Pharmacol. 2022;206:115327. https:\/\/doi.org\/10.1016\/j.bcp.2022.115327.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"641_CR181","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0926-9","volume":"37","author":"Y Peng","year":"2018","unstructured":"Peng Y, Wang Y, Tang N, Sun D, Lan Y, Yu Z, et al. Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway. J Exp Clin Cancer Res. 2018;37(1):248. https:\/\/doi.org\/10.1186\/s13046-018-0926-9.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"641_CR182","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1515\/hsz-2023-0324","volume":"405","author":"L Jia","year":"2024","unstructured":"Jia L, Zhu S, Zhu M, Nie R, Huang L, Xu S, et al. Celastrol inhibits angiogenesis and the biological processes of MDA-MB-231 cells via the DEGS1\/S1P signaling pathway. Biol Chem. 2024;405(4):267\u201381. https:\/\/doi.org\/10.1515\/hsz-2023-0324.","journal-title":"Biol Chem"},{"issue":"11","key":"641_CR183","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1002\/ptr.7292","volume":"35","author":"M Tian","year":"2021","unstructured":"Tian M, Chen K, Huang J, Chu D, Li J, Huang K, et al. Asiatic acid inhibits angiogenesis and vascular permeability through the VEGF\/VEGFR2 signaling pathway to inhibit the growth and metastasis of breast cancer in mice. Phytother Res. 2021;35(11):6389\u2013400. https:\/\/doi.org\/10.1002\/ptr.7292.","journal-title":"Phytother Res"},{"issue":"18","key":"641_CR184","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28186536","volume":"28","author":"SA Ahmed","year":"2023","unstructured":"Ahmed SA, Mendonca P, Messeha SS, Soliman KFA. Anticancer effects of fucoxanthin through cell cycle arrest, apoptosis induction, and angiogenesis inhibition in triple-negative breast cancer cells. Molecules. 2023;28(18):6536. https:\/\/doi.org\/10.3390\/molecules28186536.","journal-title":"Molecules"},{"issue":"8","key":"641_CR185","doi-asserted-by":"publisher","DOI":"10.3390\/plants9081031","volume":"9","author":"SS Elhady","year":"2020","unstructured":"Elhady SS, Eltamany EE, Shaaban AE, Bagalagel AA, Muhammad YA, El-Sayed NM, et al. Jaceidin flavonoid isolated from Chiliadenus montanus attenuates tumor progression in mice via VEGF inhibition: in vivo and in silico studies. Plants. 2020;9(8):1031. https:\/\/doi.org\/10.3390\/plants9081031.","journal-title":"Plants"},{"key":"641_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.106131","volume":"150","author":"S Tian","year":"2022","unstructured":"Tian S, Wei Y, Hu H, Zhao H. Mixed computational-experimental study to reveal the anti-metastasis and anti-angiogenesis effects of Astragalin in human breast cancer. Comput Biol Med. 2022;150:106131. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106131.","journal-title":"Comput Biol Med"},{"issue":"21","key":"641_CR187","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27217245","volume":"27","author":"AC Silveira Rabelo","year":"2022","unstructured":"Silveira Rabelo AC, Mertens-Talcott SU, Chew BP, Noratto G. Dark sweet cherry (Prunus avium) anthocyanins suppressed ERK1\/2-Akt\/mTOR cell signaling and oxidative stress: implications for TNBC growth and invasion. Molecules. 2022;27(21):7245. https:\/\/doi.org\/10.3390\/molecules27217245.","journal-title":"Molecules"},{"key":"641_CR188","doi-asserted-by":"publisher","unstructured":"Jin L, Jin L, Wu R, Liu X, Zhu X, Shou Q, et al. Hirsutella Sinensis fungus regulates CD8(+) T cell exhaustion through involvement of T-Bet\/Eomes in the tumor microenvironment. Front Pharmacol. 2020;11:612620. https:\/\/doi.org\/10.3389\/fphar.2020.612620","DOI":"10.3389\/fphar.2020.612620"},{"issue":"1","key":"641_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48073-w","volume":"13","author":"E Jalilian","year":"2023","unstructured":"Jalilian E, Abolhasani-Zadeh F, Afgar A, Samoudi A, Zeinalynezhad H, Langroudi L. Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by curcumin in breast cancer therapy. Sci Rep. 2023;13(1):20770. https:\/\/doi.org\/10.1038\/s41598-023-48073-w.","journal-title":"Sci Rep"},{"key":"641_CR190","doi-asserted-by":"publisher","unstructured":"Li H, Hou M, Zhang P, Ren L, Guo Y, Zou L, et al. Wedelolactone suppresses breast cancer growth and metastasis via regulating TGF-\u03b21\/Smad signaling pathway. J Pharm Pharmacol. 2024;76(8):1038\u201350. https:\/\/doi.org\/10.1093\/jpp\/rgae065","DOI":"10.1093\/jpp\/rgae065"},{"key":"641_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.113855","volume":"177","author":"LC Zhang","year":"2023","unstructured":"Zhang LC, Liu YN, La XQ, Li ST, Wen LN, Liu T, et al. The bound polyphenols of foxtail millet (Setaria italica) inner shell inhibit breast cancer by promoting lipid accumulation-induced autophagic death. Food Chem Toxicol. 2023;177:113855. https:\/\/doi.org\/10.1016\/j.fct.2023.113855.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"641_CR192","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01453-1","volume":"16","author":"L Yang","year":"2023","unstructured":"Yang L, Chu Z, Liu M, Zou Q, Li J, Liu Q, et al. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy. J Hematol Oncol. 2023;16(1):59. https:\/\/doi.org\/10.1186\/s13045-023-01453-1.","journal-title":"J Hematol Oncol"},{"key":"641_CR193","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1186539","volume":"13","author":"TJ Wetzel","year":"2023","unstructured":"Wetzel TJ, Erfan SC, Figueroa LD, Wheeler LM, Ananieva EA. Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment. Front Oncol. 2023;13:1186539. https:\/\/doi.org\/10.3389\/fonc.2023.1186539.","journal-title":"Front Oncol"},{"key":"641_CR194","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.1c01173","author":"A Khan","year":"2021","unstructured":"Khan A, Siddiqui S, Husain SA, Mazurek S, Iqbal MA. Phytocompounds targeting metabolic reprogramming in cancer: an assessment of role, mechanisms, pathways, and therapeutic relevance. J Agric Food Chem. 2021. https:\/\/doi.org\/10.1021\/acs.jafc.1c01173.","journal-title":"J Agric Food Chem"},{"key":"641_CR195","doi-asserted-by":"publisher","unstructured":"Craveiro M, Cretenet G, Mongellaz C, Matias MI, Caron O, de Lima MCP, et al. Resveratrol stimulates the metabolic reprogramming of human CD4(+) T cells to enhance effector function. Sci Signal. 2017;10(501). https:\/\/doi.org\/10.1126\/scisignal.aal3024","DOI":"10.1126\/scisignal.aal3024"},{"key":"641_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2021.108366","volume":"787","author":"S Delgir","year":"2021","unstructured":"Delgir S, Bastami M, Ilkhani K, Safi A, Seif F, Alivand MR. The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer. Mutat Res Rev Mutat Res. 2021;787:108366. https:\/\/doi.org\/10.1016\/j.mrrev.2021.108366.","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"1","key":"641_CR197","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.yexcr.2017.01.013","volume":"352","author":"BB Patel","year":"2017","unstructured":"Patel BB, Ackerstaff E, Serganova IS, Kerrigan JE, Blasberg RG, Koutcher JA, et al. Tumor stroma interaction is mediated by monocarboxylate metabolism. Exp Cell Res. 2017;352(1):20\u201333. https:\/\/doi.org\/10.1016\/j.yexcr.2017.01.013.","journal-title":"Exp Cell Res"},{"issue":"1","key":"641_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166565","volume":"1869","author":"A Castoldi","year":"2023","unstructured":"Castoldi A, Lee J, de Siqueira Carvalho D, Souto FO. CD8(+) T cell metabolic changes in breast cancer. Biochim Biophys Acta Mol Basis Dis. 2023;1869(1):166565. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166565.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"641_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2026.117761","volume":"247","author":"A Guo","year":"2026","unstructured":"Guo A, Yang B, Huang AX, Ni J, Zhang Y, Jiang Q, et al. Momordin Ic suppresses breast cancer growth by targeting ACTL8\u2011dependent glutamine metabolism and PI3K\/AKT\/mTOR-MYC. Biochem Pharmacol. 2026;247:117761. https:\/\/doi.org\/10.1016\/j.bcp.2026.117761.","journal-title":"Biochem Pharmacol"},{"key":"641_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115101","author":"B Zhang","year":"2022","unstructured":"Zhang B, Fu R, Duan Z, Shen S, Zhu C, Fan D. Ginsenoside CK induces apoptosis in triple-negative breast cancer cells by targeting glutamine metabolism. Biochem Pharmacol. 2022. https:\/\/doi.org\/10.1016\/j.bcp.2022.115101.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"641_CR201","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41416-023-02245-7","volume":"129","author":"HN Girithar","year":"2023","unstructured":"Girithar HN, Staats Pires A, Ahn SB, Guillemin GJ, Gluch L, Heng B. Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials. Br J Cancer. 2023;129(2):185\u2013203. https:\/\/doi.org\/10.1038\/s41416-023-02245-7.","journal-title":"Br J Cancer"},{"key":"641_CR202","doi-asserted-by":"publisher","unstructured":"Sarangi P. Role of indoleamine 2, 3-dioxygenase 1 in immunosuppression of breast cancer. Cancer Pathog Ther. 2024;2(4):246\u201355. https:\/\/doi.org\/10.1016\/j.cpt.2023.11.001","DOI":"10.1016\/j.cpt.2023.11.001"},{"key":"641_CR203","doi-asserted-by":"publisher","unstructured":"Calderon JJ, Prieto K, Lasso P, Fiorentino S, Barreto A. Modulation of myeloid-derived suppressor cells in the tumor microenvironment by natural products. Arch Immunol Ther Exp (Warsz). 2023;71(1):17. https:\/\/doi.org\/10.1007\/s00005-023-00681-0","DOI":"10.1007\/s00005-023-00681-0"},{"key":"641_CR204","doi-asserted-by":"publisher","unstructured":"Martinenaite E, Lecoq I, Aaboe-J\u00f8rgensen M, Ahmad SM, Perez-Penco M, Gl\u00f6ckner HJ, et al. Arginase-1-specific T cells target and modulate tumor-associated macrophages. J Immunother Cancer. 2025;13(1). https:\/\/doi.org\/10.1136\/jitc-2024-009930","DOI":"10.1136\/jitc-2024-009930"},{"key":"641_CR205","doi-asserted-by":"publisher","unstructured":"Cao Y, Feng Y, Zhang Y, Zhu X, Jin F. L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo. BMC Cancer. 2016;16:343. https:\/\/doi.org\/10.1186\/s12885-016-2376-0","DOI":"10.1186\/s12885-016-2376-0"},{"key":"641_CR206","doi-asserted-by":"publisher","first-page":"1 e3914","DOI":"10.1002\/cbf.3914","volume":"42","author":"M Ginovyan","year":"2024","unstructured":"Ginovyan M, Javrushyan H, Karapetyan H, Koss-Miko\u0142ajczyk I, Kusznierewicz B, Grigoryan A, et al. Hypericum alpestre extract exhibits in vitro and in vivo anticancer properties by regulating the cellular antioxidant system and metabolic pathway of L-arginine. Cell Biochem Funct. 2024;42:1 e3914. https:\/\/doi.org\/10.1002\/cbf.3914.","journal-title":"Cell Biochem Funct"},{"key":"641_CR207","doi-asserted-by":"publisher","first-page":"154508","DOI":"10.1016\/j.phymed.2022.154508","volume":"108","author":"L Li","year":"2023","unstructured":"Li L, You W, Wang X, Zou Y, Yao H, Lan H, et al. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression. Phytomedicine. 2023;108:154508. https:\/\/doi.org\/10.1016\/j.phymed.2022.154508.","journal-title":"Phytomedicine"},{"key":"641_CR208","doi-asserted-by":"publisher","first-page":"113887","DOI":"10.1016\/j.bcp.2020.113887","volume":"176","author":"X Zheng","year":"2020","unstructured":"Zheng X, Fernando V, Sharma V, Walia Y, Letson J, Furuta S. Correction of arginine metabolism with sepiapterin-the precursor of nitric oxide synthase cofactor BH(4)-induces immunostimulatory-shift of breast cancer. Biochem Pharmacol. 2020;176:113887. https:\/\/doi.org\/10.1016\/j.bcp.2020.113887.","journal-title":"Biochem Pharmacol"},{"key":"641_CR209","doi-asserted-by":"publisher","first-page":"1615631","DOI":"10.3389\/fimmu.2025.1615631","volume":"16","author":"C Yu","year":"2025","unstructured":"Yu C, Jia C, Chen G, Li Y, Liu Y, Zhang Y. Yiai Fuzheng decoction inhibits triple-negative breast cancer by remodeling the immune microenvironment. Front Immunol. 2025;16:1615631. https:\/\/doi.org\/10.3389\/fimmu.2025.1615631.","journal-title":"Front Immunol"},{"issue":"4","key":"641_CR210","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1158\/1541-7786.Mcr-19-0606","volume":"18","author":"AM Li","year":"2020","unstructured":"Li AM, Ducker GS, Li Y, Seoane JA, Xiao Y, Melemenidis S, et al. Metabolic profiling reveals a dependency of human metastatic Breast Cancer on mitochondrial serine and one-carbon unit metabolism. Mol Cancer Res. 2020;18(4):599\u2013611. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-19-0606.","journal-title":"Mol Cancer Res"},{"issue":"6","key":"641_CR211","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/biof.1776","volume":"47","author":"X Fu","year":"2021","unstructured":"Fu X, He Y, Li M, Huang Z, Najafi M. Targeting of the tumor microenvironment by curcumin. BioFactors. 2021;47(6):914\u201332. https:\/\/doi.org\/10.1002\/biof.1776.","journal-title":"BioFactors"},{"issue":"6","key":"641_CR212","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.5114\/aoms\/171122","volume":"19","author":"M Zahedi","year":"2023","unstructured":"Zahedi M, Salmani Izadi H, Arghidash F, Gumpricht E, Banach M, Sahebkar A. The effect of curcumin on hypoxia in the tumour microenvironment as a regulatory factor in cancer. Arch Med Sci. 2023;19(6):1616\u201329. https:\/\/doi.org\/10.5114\/aoms\/171122.","journal-title":"Arch Med Sci"},{"issue":"1","key":"641_CR213","doi-asserted-by":"publisher","DOI":"10.1515\/biol-2025-1089","volume":"20","author":"X Han","year":"2025","unstructured":"Han X, Tang R, Wang P, Liu L. Research progress on the impact of curcumin on immune responses in breast cancer. Open Life Sci. 2025;20(1):20251089. https:\/\/doi.org\/10.1515\/biol-2025-1089.","journal-title":"Open Life Sci"},{"key":"641_CR214","doi-asserted-by":"publisher","unstructured":"Jang BY, Shin MK, Han DH, Sung JS. Curcumin disrupts a positive feedback loop between ADMSCs and cancer cells in the breast tumor microenvironment via the CXCL12\/CXCR4 Axis. Pharmaceutics. 2023;15(11). https:\/\/doi.org\/10.3390\/pharmaceutics15112627","DOI":"10.3390\/pharmaceutics15112627"},{"issue":"11","key":"641_CR215","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1055\/a-1201-2602","volume":"70","author":"MA Sarighieh","year":"2020","unstructured":"Sarighieh MA, Montazeri V, Shadboorestan A, Ghahremani MH, Ostad SN. The inhibitory effect of curcumin on hypoxia inducer factors (Hifs) as a regulatory factor in the growth of tumor cells in breast cancer stem-like cells. Drug Res (Stuttg). 2020;70(11):512\u20138. https:\/\/doi.org\/10.1055\/a-1201-2602.","journal-title":"Drug Res (Stuttg)"},{"key":"641_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2021.108842","volume":"99","author":"AG Kunihiro","year":"2022","unstructured":"Kunihiro AG, Brickey JA, Frye JB, Cheng JN, Luis PB, Schneider C, et al. Curcumin inhibition of TGF\u03b2 signaling in bone metastatic breast cancer cells and the possible role of oxidative metabolites. J Nutr Biochem. 2022;99:108842. https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108842.","journal-title":"J Nutr Biochem"},{"key":"641_CR217","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116690","volume":"232","author":"M Li","year":"2025","unstructured":"Li M, Chen L, Wang M, Huang X, Ke Q, Hu C. Curcumin alleviates the aggressiveness of breast cancer through inhibiting cell adhesion mediated by TEAD4-fibronectin axis. Biochem Pharmacol. 2025;232:116690. https:\/\/doi.org\/10.1016\/j.bcp.2024.116690.","journal-title":"Biochem Pharmacol"},{"key":"641_CR218","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1515605","volume":"16","author":"B Ding","year":"2025","unstructured":"Ding B, Li J, Yan JL, Jiang CY, Qian LB, Pan J. Resveratrol contributes to NK cell-mediated breast cancer cytotoxicity by upregulating ULBP2 through miR-17-5p downmodulation and activation of MINK1\/JNK\/c-Jun signaling. Front Immunol. 2025;16:1515605. https:\/\/doi.org\/10.3389\/fimmu.2025.1515605.","journal-title":"Front Immunol"},{"key":"641_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104423","volume":"368","author":"X Han","year":"2021","unstructured":"Han X, Zhao N, Zhu W, Wang J, Liu B, Teng Y. Resveratrol attenuates TNBC lung metastasis by down-regulating PD-1 expression on pulmonary T cells and converting macrophages to M1 phenotype in a murine tumor model. Cell Immunol. 2021;368:104423. https:\/\/doi.org\/10.1016\/j.cellimm.2021.104423.","journal-title":"Cell Immunol"},{"key":"641_CR220","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114451","volume":"153","author":"Y Shi","year":"2025","unstructured":"Shi Y, Cai G, Zhang C, Li H, Nie Y, Yu S, et al. Resveratrol suppresses growth and VCAN expression in a cancer-associated fibroblast-breast cancer hybrid organoid. Int Immunopharmacol. 2025;153:114451. https:\/\/doi.org\/10.1016\/j.intimp.2025.114451.","journal-title":"Int Immunopharmacol"},{"key":"641_CR221","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.2147\/ijn.S492145","volume":"20","author":"C Geng","year":"2025","unstructured":"Geng C, Yan L, Li Y, Li H, Ji Y, Xiao Y, et al. Layered double hydroxide nanoparticles loaded with resveratrol inhibit glycolysis and show efficacy in the treatment of breast cancer. Int J Nanomed. 2025;20:3423\u201344. https:\/\/doi.org\/10.2147\/ijn.S492145.","journal-title":"Int J Nanomed"},{"issue":"1","key":"641_CR222","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ptr.7608","volume":"37","author":"J Wang","year":"2023","unstructured":"Wang J, Huang P, Pan X, Xia C, Zhang H, Zhao H, et al. Resveratrol reverses TGF-\u03b21-mediated invasion and metastasis of breast cancer cells via the SIRT3\/AMPK\/autophagy signal axis. Phytother Res. 2023;37(1):211\u201330. https:\/\/doi.org\/10.1002\/ptr.7608.","journal-title":"Phytother Res"},{"key":"641_CR223","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2022.01.010","volume":"180","author":"T Cheng","year":"2022","unstructured":"Cheng T, Wang C, Lu Q, Cao Y, Yu W, Li W, et al. Metformin inhibits the tumor-promoting effect of low-dose resveratrol, and enhances the anti-tumor activity of high-dose resveratrol by increasing its reducibility in triple negative breast cancer. Free Radic Biol Med. 2022;180:108\u201320. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.01.010.","journal-title":"Free Radic Biol Med"},{"key":"641_CR224","doi-asserted-by":"publisher","DOI":"10.3390\/nu14051099","author":"N Gonzalez Suarez","year":"2022","unstructured":"Gonzalez Suarez N, Fernandez-Marrero Y, Torabidastgerdooei S, Annabi B. EGCG prevents the onset of an inflammatory and cancer-associated adipocyte-like phenotype in adipose-derived mesenchymal stem\/stromal cells in response to the triple-negative breast cancer secretome. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14051099.","journal-title":"Nutrients"},{"issue":"1","key":"641_CR225","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03087-2","volume":"23","author":"N Gonzalez Suarez","year":"2023","unstructured":"Gonzalez Suarez N, Fernandez-Marrero Y, H\u00e9bert MPA, Roy ME, Boudreau LH, Annabi B. EGCG inhibits the inflammation and senescence inducing properties of MDA-MB-231 triple-negative breast cancer (TNBC) cells-derived extracellular vesicles in human adipose-derived mesenchymal stem cells. Cancer Cell Int. 2023;23(1):240. https:\/\/doi.org\/10.1186\/s12935-023-03087-2.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"641_CR226","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.apsb.2021.08.016","volume":"12","author":"Q Chen","year":"2022","unstructured":"Chen Q, Li Q, Liang Y, Zu M, Chen N, Canup BSB, et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharm Sin B. 2022;12(2):907\u201323. https:\/\/doi.org\/10.1016\/j.apsb.2021.08.016.","journal-title":"Acta Pharm Sin B"},{"issue":"14","key":"641_CR227","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202406245","volume":"21","author":"M Zhou","year":"2025","unstructured":"Zhou M, Zhou C, Geng H, Huang Z, Lin Z, Wang Y, et al. EGCG-enabled deep tumor penetration of phosphatase and acidity dual-responsive nanotherapeutics for combinatory therapy of breast cancer. Small. 2025;21(14):e2406245. https:\/\/doi.org\/10.1002\/smll.202406245.","journal-title":"Small"},{"issue":"1","key":"641_CR228","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39279-z","volume":"13","author":"C Li","year":"2023","unstructured":"Li C, Xu Y, Zhang J, Zhang Y, He W, Ju J, et al. The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice. Sci Rep. 2023;13(1):13278. https:\/\/doi.org\/10.1038\/s41598-023-39279-z.","journal-title":"Sci Rep"},{"issue":"5","key":"641_CR229","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.apsb.2023.12.001","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang L, He S, Liu R, Xue Y, Quan Y, Shi R, et al. A pH\/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment. Acta Pharm Sin B. 2024;14(5):2263\u201380. https:\/\/doi.org\/10.1016\/j.apsb.2023.12.001.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"641_CR230","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10828-1","volume":"52","author":"SK Pepin","year":"2025","unstructured":"Pepin SK, Zgheib A, Roy ME, Annabi B. Quercetin targets TGF\u03b2-primed human MDA-MB-231 triple-negative breast cancer cells, linking epithelial-mesenchymal transition to cell senescence and fibrosis. Mol Biol Rep. 2025;52(1):725. https:\/\/doi.org\/10.1007\/s11033-025-10828-1.","journal-title":"Mol Biol Rep"},{"key":"641_CR231","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.lfs.2018.07.027","volume":"208","author":"L Jia","year":"2018","unstructured":"Jia L, Huang S, Yin X, Zan Y, Guo Y, Han L. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Life Sci. 2018;208:123\u201330. https:\/\/doi.org\/10.1016\/j.lfs.2018.07.027.","journal-title":"Life Sci"},{"issue":"4","key":"641_CR232","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s12282-022-01356-y","volume":"29","author":"B Ruidas","year":"2022","unstructured":"Ruidas B, Sur TK, Das Mukhopadhyay C, Sinha K, Som Chaudhury S, Sharma P, et al. Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1. Breast Cancer. 2022;29(4):748\u201360. https:\/\/doi.org\/10.1007\/s12282-022-01356-y.","journal-title":"Breast Cancer"},{"issue":"5","key":"641_CR233","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1021\/acsnano.7b01522","volume":"11","author":"K Hu","year":"2017","unstructured":"Hu K, Miao L, Goodwin TJ, Li J, Liu Q, Huang L. Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles. ACS Nano. 2017;11(5):4916\u201325. https:\/\/doi.org\/10.1021\/acsnano.7b01522.","journal-title":"ACS Nano"},{"key":"641_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.125134","volume":"670","author":"Y Shi","year":"2025","unstructured":"Shi Y, Cao L, Zhao W, Lai S, Chen Z, Ye Z, et al. Enhancing chemo-immunotherapy in triple-negative breast cancer: co-delivery of doxorubicin and berberine using nanoparticles to downregulate PD-L1 and eliminate cancer stem cells. Int J Pharm. 2025;670:125134. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.125134.","journal-title":"Int J Pharm"},{"key":"641_CR235","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123898","volume":"653","author":"J Sun","year":"2024","unstructured":"Sun J, Ye T, Chen X, Li B, Wei Y, Zheng H, et al. A self-assembly active nanomodulator based on berberine for photothermal immunotherapy of breast cancer via dual regulation of immune suppression. Int J Pharm. 2024;653:123898. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123898.","journal-title":"Int J Pharm"},{"key":"641_CR236","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2024.104908","volume":"408","author":"J Xie","year":"2025","unstructured":"Xie J, Du X, Li Y, Wu C, Li R, Zhao M, et al. Berberine shaping the tumor immune landscape via pyroptosis. Cell Immunol. 2025;408:104908. https:\/\/doi.org\/10.1016\/j.cellimm.2024.104908.","journal-title":"Cell Immunol"},{"key":"641_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106787","volume":"87","author":"W Ma","year":"2020","unstructured":"Ma W, Zhang Y, Yu M, Wang B, Xu S, Zhang J, et al. In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects. Int Immunopharmacol. 2020;87:106787. https:\/\/doi.org\/10.1016\/j.intimp.2020.106787.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"641_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdnut.2024.104532","volume":"9","author":"N Ibrahim","year":"2025","unstructured":"Ibrahim N, Alsadi N, Yasavoli-Sharahi H, Shahbazi R, Hebbo MJ, Kambli D, et al. Berberine inhibits breast cancer stem cell development and decreases inflammation: involvement of miRNAs and IL-6. Curr Dev Nutr. 2025;9(2):104532. https:\/\/doi.org\/10.1016\/j.cdnut.2024.104532.","journal-title":"Curr Dev Nutr"},{"issue":"7","key":"641_CR239","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70375","volume":"39","author":"NE El-Ashmawy","year":"2025","unstructured":"El-Ashmawy NE, Khedr EG, El-Adawy SA, Khedr NF. Berberine-induced cytotoxicity in breast cancer is mediated by reversal of EMT and repression of Sirtuin 1\/AKT signaling pathways. J Biochem Mol Toxicol. 2025;39(7):e70375. https:\/\/doi.org\/10.1002\/jbt.70375.","journal-title":"J Biochem Mol Toxicol"},{"issue":"17","key":"641_CR240","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/1759-7714.15321","volume":"15","author":"W Fu","year":"2024","unstructured":"Fu W, Liu L, Tong S. Berberine inhibits the progression of breast cancer by regulating METTL3-mediated m6A modification of FGF7 mRNA. Thorac Cancer. 2024;15(17):1357\u201368. https:\/\/doi.org\/10.1111\/1759-7714.15321.","journal-title":"Thorac Cancer"},{"issue":"16","key":"641_CR241","doi-asserted-by":"publisher","first-page":"10645","DOI":"10.1021\/acsomega.0c06288","volume":"6","author":"K Qian","year":"2021","unstructured":"Qian K, Tang CY, Chen LY, Zheng S, Zhao Y, Ma LS, et al. Berberine reverses breast cancer multidrug resistance based on fluorescence pharmacokinetics in vitro and in vivo. ACS Omega. 2021;6(16):10645\u201354. https:\/\/doi.org\/10.1021\/acsomega.0c06288.","journal-title":"ACS Omega"},{"key":"641_CR242","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3617514","volume":"2020","author":"L Zhao","year":"2020","unstructured":"Zhao L, Zhang C. Berberine inhibits MDA-MB-231 cells by attenuating their inflammatory responses. BioMed Res Int. 2020;2020:3617514. https:\/\/doi.org\/10.1155\/2020\/3617514.","journal-title":"BioMed Res Int"},{"key":"641_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.117158","volume":"494","author":"Z Deng","year":"2025","unstructured":"Deng Z, Ou M, Shi Y, Li G, Lv L. Ginsenoside Rg3 attenuates the stemness of breast cancer stem cells by activating the hippo signaling pathway. Toxicol Appl Pharmacol. 2025;494:117158. https:\/\/doi.org\/10.1016\/j.taap.2024.117158.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"641_CR244","doi-asserted-by":"publisher","first-page":"601","DOI":"10.62347\/gyxe7741","volume":"14","author":"JY Ning","year":"2024","unstructured":"Ning JY, Zhang ZH, Zhang J, Liu YM, Li GC, Wang AM. Ginsenoside Rg3 decreases breast cancer stem-like phenotypes through impairing MYC mRNA stability. Am J Cancer Res. 2024;14(2):601\u201315. https:\/\/doi.org\/10.62347\/gyxe7741.","journal-title":"Am J Cancer Res"},{"key":"641_CR245","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9281","volume":"8","author":"P Wang","year":"2020","unstructured":"Wang P, Song D, Wan D, Li L, Mei W, Li X, et al. Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1\/NF-\u03baB and ERK pathways. PeerJ. 2020;8:e9281. https:\/\/doi.org\/10.7717\/peerj.9281.","journal-title":"PeerJ"},{"key":"641_CR246","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109891","volume":"124","author":"H Gao","year":"2020","unstructured":"Gao H, Liang D, Li C, Xu G, Jiang M, Li H, et al. 2-Deoxy-Rh2: a novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis. Biomed Pharmacother. 2020;124:109891. https:\/\/doi.org\/10.1016\/j.biopha.2020.109891.","journal-title":"Biomed Pharmacother"},{"key":"641_CR247","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1483896","volume":"15","author":"R Ding","year":"2024","unstructured":"Ding R, Kan Q, Wang T, Xiao R, Song Y, Li D. Ginsenoside Rh2 regulates triple-negative breast cancer proliferation and apoptosis via the IL-6\/JAK2\/STAT3 pathway. Front Pharmacol. 2024;15:1483896. https:\/\/doi.org\/10.3389\/fphar.2024.1483896.","journal-title":"Front Pharmacol"},{"key":"641_CR248","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910458","author":"Y Jin","year":"2021","unstructured":"Jin Y, Huynh DTN, Myung CS, Heo KS. Ginsenoside Rh1 prevents migration and invasion through mitochondrial ROS-mediated inhibition of STAT3\/NF-\u03baB signaling in MDA-MB-231 cells. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms221910458.","journal-title":"Int J Mol Sci"},{"key":"641_CR249","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8886955","volume":"2020","author":"Y Chu","year":"2020","unstructured":"Chu Y, Zhang W, Kanimozhi G, Brindha GR, Tian D. Ginsenoside Rg1 induces apoptotic cell death in triple-negative breast cancer cell lines and prevents carcinogen-induced breast tumorigenesis in Sprague Dawley rats. Evid Based Complement Alternat Med. 2020;2020:8886955. https:\/\/doi.org\/10.1155\/2020\/8886955.","journal-title":"Evid Based Complement Alternat Med"},{"key":"641_CR250","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123718","volume":"650","author":"J Long","year":"2024","unstructured":"Long J, Hu W, Ren T, Wang X, Lu C, Pan X, et al. Combating multidrug resistance of breast cancer with ginsenoside Rh2-irrigated nano-in-thermogel. Int J Pharm. 2024;650:123718. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123718.","journal-title":"Int J Pharm"},{"issue":"6","key":"641_CR251","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13246","volume":"55","author":"J Hou","year":"2022","unstructured":"Hou J, Yun Y, Cui C, Kim S. Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice. Cell Prolif. 2022;55(6):e13246. https:\/\/doi.org\/10.1111\/cpr.13246.","journal-title":"Cell Prolif"},{"key":"641_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.crbiot.2025.100300","volume":"10","author":"SS Abuzahrah","year":"2025","unstructured":"Abuzahrah SS, Elbehairi SEI, Bakhsh T, Atwa A, Juaid N, Mekky RH. Marine-derived secondary metabolites in oncology: a comprehensive review. Curr Res Biotechnol. 2025;10:100300.","journal-title":"Curr Res Biotechnol"},{"issue":"3","key":"641_CR253","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/jcmm.14151","volume":"23","author":"J Wang","year":"2019","unstructured":"Wang J, Ma Y, Yang J, Jin L, Gao Z, Xue L, et al. Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer. J Cell Mol Med. 2019;23(3):2219\u201329. https:\/\/doi.org\/10.1111\/jcmm.14151.","journal-title":"J Cell Mol Med"},{"key":"641_CR254","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29010061","author":"SA Ahmed","year":"2023","unstructured":"Ahmed SA, Mendonca P, Messeha SS, Oriaku ET, Soliman KFA. The anticancer effects of marine carotenoid fucoxanthin through phosphatidylinositol 3-kinase (PI3K)-AKT signaling on triple-negative breast cancer cells. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules29010061.","journal-title":"Molecules"},{"key":"641_CR255","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.960375","volume":"13","author":"W Wang","year":"2022","unstructured":"Wang W, Fu C, Lin M, Lu Y, Lian S, Xie X, et al. Fucoxanthin prevents breast cancer metastasis by interrupting circulating tumor cells adhesion and transendothelial migration. Front Pharmacol. 2022;13:960375. https:\/\/doi.org\/10.3389\/fphar.2022.960375.","journal-title":"Front Pharmacol"},{"key":"641_CR256","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jare.2024.04.017","volume":"70","author":"Z Wu","year":"2025","unstructured":"Wu Z, Tang Y, Liu Y, Chen Z, Feng Y, Hu H, et al. Co-delivery of fucoxanthin and Twist siRNA using hydroxyethyl starch-cholesterol self-assembled polymer nanoparticles for triple-negative breast cancer synergistic therapy. J Adv Res. 2025;70:463\u201379. https:\/\/doi.org\/10.1016\/j.jare.2024.04.017.","journal-title":"J Adv Res"},{"key":"641_CR257","doi-asserted-by":"publisher","DOI":"10.3390\/md20060370","author":"TY Lau","year":"2022","unstructured":"Lau TY, Kwan HY. Fucoxanthin is a potential therapeutic agent for the treatment of breast cancer. Mar Drugs. 2022. https:\/\/doi.org\/10.3390\/md20060370.","journal-title":"Mar Drugs"},{"issue":"1","key":"641_CR258","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3892\/ol.2019.10283","volume":"18","author":"W Li","year":"2019","unstructured":"Li W, Xue D, Xue M, Zhao J, Liang H, Liu Y, et al. Fucoidan inhibits epithelial-to-mesenchymal transition via regulation of the HIF-1\u03b1 pathway in mammary cancer cells under hypoxia. Oncol Lett. 2019;18(1):330\u20138. https:\/\/doi.org\/10.3892\/ol.2019.10283.","journal-title":"Oncol Lett"},{"key":"641_CR259","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120227","volume":"257","author":"CH Chung","year":"2020","unstructured":"Chung CH, Lu KY, Lee WC, Hsu WJ, Lee WF, Dai JZ, et al. Fucoidan-based, tumor-activated nanoplatform for overcoming hypoxia and enhancing photodynamic therapy and antitumor immunity. Biomaterials. 2020;257:120227. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120227.","journal-title":"Biomaterials"},{"key":"641_CR260","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.ijbiomac.2020.01.256","volume":"149","author":"WJ Hsu","year":"2020","unstructured":"Hsu WJ, Lin MH, Kuo TC, Chou CM, Mi FL, Cheng CH, et al. Fucoidan from Laminaria japonica exerts antitumor effects on angiogenesis and micrometastasis in triple-negative breast cancer cells. Int J Biol Macromol. 2020;149:600\u20138. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.01.256.","journal-title":"Int J Biol Macromol"},{"issue":"42","key":"641_CR261","doi-asserted-by":"publisher","first-page":"29121","DOI":"10.1021\/acsnano.4c10603","volume":"18","author":"X Cheng","year":"2024","unstructured":"Cheng X, He C, Huang J, Li J, Hu Z, Wang L, et al. A tumor-homing nanoframework for synergistic microwave tumor ablation and provoking strong anticancer immunity against metastasis. ACS Nano. 2024;18(42):29121\u201339. https:\/\/doi.org\/10.1021\/acsnano.4c10603.","journal-title":"ACS Nano"},{"issue":"8104","key":"641_CR262","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-025-09913-z","volume":"651","author":"TA Najar","year":"2026","unstructured":"Najar TA, Hao Y, Hao Y, Romero-Meza G, Dolynuk A, Almo E, et al. Microbiota-induced T cell plasticity enables immune-mediated tumour control. Nature. 2026;651(8104):201\u201310. https:\/\/doi.org\/10.1038\/s41586-025-09913-z.","journal-title":"Nature"},{"key":"641_CR263","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28155804","author":"LL Kan","year":"2023","unstructured":"Kan LL, Chan BC, Leung PC, Wong CK. Natural-product-derived adjunctive treatments to conventional therapy and their immunoregulatory activities in triple-negative breast cancer. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28155804.","journal-title":"Molecules"},{"key":"641_CR264","doi-asserted-by":"publisher","unstructured":"Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial. Lancet. 2020;396(10265):1817\u201328. https:\/\/doi.org\/10.1016\/s0140-6736(20)32531-9","DOI":"10.1016\/s0140-6736(20)32531-9"},{"issue":"1","key":"641_CR265","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39607-x","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Zhang R, He J, Yu L, Li X, Zhang J, et al. Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity. Nat Commun. 2023;14(1):3877. https:\/\/doi.org\/10.1038\/s41467-023-39607-x.","journal-title":"Nat Commun"},{"key":"641_CR266","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157017","volume":"145","author":"Q Xu","year":"2025","unstructured":"Xu Q, Jiang Z, Pan Y, Li S, Cao Z, Hua S, et al. Cucurbitacin B stimulates PD-1 immunotherapy response in malignant breast cancer by covalent targeting MTCH2. Phytomedicine. 2025;145:157017. https:\/\/doi.org\/10.1016\/j.phymed.2025.157017.","journal-title":"Phytomedicine"},{"issue":"1","key":"641_CR267","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-022-00638-z","volume":"17","author":"Q Sun","year":"2022","unstructured":"Sun Q, Xiao L, Cui Z, Yang Y, Ma J, Huang Z, et al. 3,3\u2019-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells. Chin Med. 2022;17(1):81. https:\/\/doi.org\/10.1186\/s13020-022-00638-z.","journal-title":"Chin Med"},{"issue":"1","key":"641_CR268","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04312-2","volume":"21","author":"H Tan","year":"2023","unstructured":"Tan H, Liu J, Huang J, Li Y, Xie Q, Dong Y, et al. Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1. J Transl Med. 2023;21(1):462. https:\/\/doi.org\/10.1186\/s12967-023-04312-2.","journal-title":"J Transl Med"},{"key":"641_CR269","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218038","volume":"633","author":"Z Wang","year":"2025","unstructured":"Wang Z, Gu Z, Mo W, Zhang H. Lactate metabolic checkpoint in immuno-oncology: mechanisms and therapeutic implications. Cancer Lett. 2025;633:218038. https:\/\/doi.org\/10.1016\/j.canlet.2025.218038.","journal-title":"Cancer Lett"},{"key":"641_CR270","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119769","volume":"235","author":"H Xu","year":"2020","unstructured":"Xu H, Hu M, Liu M, An S, Guan K, Wang M, et al. Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model. Biomaterials. 2020;235:119769. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119769.","journal-title":"Biomaterials"},{"key":"641_CR271","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137077","author":"H Huang","year":"2024","unstructured":"Huang H, Li X, Wu W, Liu C, Shao Y, Wu X, et al. Cordycepin enhances the therapeutic efficacy of Doxorubicin in treating triple-negative breast cancer. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25137077.","journal-title":"Int J Mol Sci"},{"issue":"44","key":"641_CR272","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1038\/s41388-023-02837-w","volume":"42","author":"Z Liu","year":"2023","unstructured":"Liu Z, Hou P, Fang J, Zhu J, Zha J, Liu R, et al. Mesenchymal stromal cells confer breast cancer doxorubicin resistance by producing hyaluronan. Oncogene. 2023;42(44):3221\u201335. https:\/\/doi.org\/10.1038\/s41388-023-02837-w.","journal-title":"Oncogene"},{"key":"641_CR273","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157330","volume":"148","author":"B Bai","year":"2025","unstructured":"Bai B, Zhang L, Zhang Y, Yue R, Lu Y, Shi R, et al. Astragaloside IV potentiates cisplatin sensitivity in triple-negative breast cancer via STING signaling pathway activation. Phytomedicine. 2025;148:157330. https:\/\/doi.org\/10.1016\/j.phymed.2025.157330.","journal-title":"Phytomedicine"},{"issue":"3","key":"641_CR274","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s12079-022-00692-0","volume":"17","author":"D Nayak","year":"2023","unstructured":"Nayak D, Paul S, Das C, Bhal S, Kundu CN. Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A. J Cell Commun Signal. 2023;17(3):609\u201326. https:\/\/doi.org\/10.1007\/s12079-022-00692-0.","journal-title":"J Cell Commun Signal"},{"key":"641_CR275","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112599","volume":"146","author":"NH Shehatta","year":"2022","unstructured":"Shehatta NH, Okda TM, Omran GA, Abd-Alhaseeb MM. Baicalin; a promising chemopreventive agent, enhances the antitumor effect of 5-FU against breast cancer and inhibits tumor growth and angiogenesis in Ehrlich solid tumor. Biomed Pharmacother. 2022;146:112599. https:\/\/doi.org\/10.1016\/j.biopha.2021.112599.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"641_CR276","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-65508-0","volume":"14","author":"AN Hakeem","year":"2024","unstructured":"Hakeem AN, El-Kersh DM, Hammam O, Elhosseiny A, Zaki A, Kamel K, et al. Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K\/Akt\/mTOR pathway and cancer stem cells. Sci Rep. 2024;14(1):18181. https:\/\/doi.org\/10.1038\/s41598-024-65508-0.","journal-title":"Sci Rep"},{"key":"641_CR277","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157275","volume":"148","author":"Y Li","year":"2025","unstructured":"Li Y, Zhang H, Wei J, Jin W, Tong Q, Ye Y, et al. Celastrol liposomes enhance anti-PD-L1 in triple-negative breast cancer by reprogramming immunosuppressive microenvironment driven by cancer-associated adipocytes. Phytomedicine. 2025;148:157275. https:\/\/doi.org\/10.1016\/j.phymed.2025.157275.","journal-title":"Phytomedicine"},{"key":"641_CR278","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156514","volume":"139","author":"J Huang","year":"2025","unstructured":"Huang J, Shi J, Ma N, Li Y, Jin W, Zhang H, et al. Celastrol-loaded ginsenoside Rg3 liposomes enhance anti-programmed death ligand 1 immunotherapy by inducing immunogenic cell death in triple-negative breast cancer. Phytomedicine. 2025;139:156514. https:\/\/doi.org\/10.1016\/j.phymed.2025.156514.","journal-title":"Phytomedicine"},{"key":"641_CR279","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112759","volume":"140","author":"N Luo","year":"2024","unstructured":"Luo N, Ma L, Ma N, Wei J, Zhang H, Jin W, et al. Hesperidin PLGA nanoparticles potentiate the efficacy of aPD-1 in treating triple negative breast cancer by regulating CCL2 and ADPN expression in cancer-associated adipocytes. Int Immunopharmacol. 2024;140:112759. https:\/\/doi.org\/10.1016\/j.intimp.2024.112759.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"641_CR280","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/cam4.1993","volume":"8","author":"X Jin","year":"2019","unstructured":"Jin X, Wei Y, Liu Y, Lu X, Ding F, Wang J, et al. Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1\/\u03b2-catenin signaling pathway in breast cancer. Cancer Med. 2019;8(3):1246\u201357. https:\/\/doi.org\/10.1002\/cam4.1993.","journal-title":"Cancer Med"},{"issue":"18","key":"641_CR281","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1111\/jcmm.17902","volume":"27","author":"E Shakiba","year":"2023","unstructured":"Shakiba E, Bazi A, Ghasemi H, Eshaghi-Gorji R, Mehdipour SA, Nikfar B, et al. Hesperidin suppressed metastasis, angiogenesis and tumour growth in Balb\/c mice model of breast cancer. J Cell Mol Med. 2023;27(18):2756\u201369. https:\/\/doi.org\/10.1111\/jcmm.17902.","journal-title":"J Cell Mol Med"},{"key":"641_CR282","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101634","volume":"32","author":"L Wei","year":"2025","unstructured":"Wei L, Wang H, Ye X, Yue J, Guo H, Mao D, et al. Oxymatrine and astragaloside IV co-loaded liposomes: scale-up purposes and their enhancement of anti-PD-1 efficacy against breast cancer. Mater Today Bio. 2025;32:101634. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101634.","journal-title":"Mater Today Bio"},{"key":"641_CR283","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2025.214380","volume":"177","author":"J Liu","year":"2025","unstructured":"Liu J, Xiao S, Huang C, Zhang X, Cai R, Qu S, et al. Emodin nanoparticles-loaded injectable hydrogel with deep tumor penetration for triple-negative breast cancer therapy. Biomater Adv. 2025;177:214380. https:\/\/doi.org\/10.1016\/j.bioadv.2025.214380.","journal-title":"Biomater Adv"},{"key":"641_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122778","volume":"635","author":"F Zheng","year":"2023","unstructured":"Zheng F, Luo Y, Liu Y, Gao Y, Chen W, Wei K. Nano-baicalein facilitates chemotherapy in breast cancer by targeting tumor microenvironment. Int J Pharm. 2023;635:122778. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122778.","journal-title":"Int J Pharm"},{"issue":"Pt 4","key":"641_CR285","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136484","volume":"281","author":"J Wu","year":"2024","unstructured":"Wu J, Li Y, Sun S, Li W, Sun J, Zhu L, et al. The pH-sensitive chondroitin sulphate-based nanoparticles for co-delivery of doxorubicin and berberine enhance the treatment of breast cancer. Int J Biol Macromol. 2024;281(Pt 4):136484. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136484.","journal-title":"Int J Biol Macromol"},{"key":"641_CR286","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.600579","volume":"9","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Xiao W, Peng W, Huang Q, Wu K, Evans CE, et al. Oridonin-loaded nanoparticles inhibit breast cancer progression through regulation of ROS-related Nrf2 signaling pathway. Front Bioeng Biotechnol. 2021;9:600579. https:\/\/doi.org\/10.3389\/fbioe.2021.600579.","journal-title":"Front Bioeng Biotechnol"},{"key":"641_CR287","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120716","volume":"271","author":"X Zheng","year":"2021","unstructured":"Zheng X, Zhao Y, Jia Y, Shao D, Zhang F, Sun M, et al. Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis. Biomaterials. 2021;271:120716. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120716.","journal-title":"Biomaterials"},{"key":"641_CR288","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120333","volume":"598","author":"S Wu","year":"2021","unstructured":"Wu S, Liu D, Li W, Song B, Chen C, Chen D, et al. Enhancing TNBC chemo-immunotherapy via combination reprogramming tumor immune microenvironment with immunogenic cell death. Int J Pharm. 2021;598:120333. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120333.","journal-title":"Int J Pharm"},{"issue":"9","key":"641_CR289","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4103\/apjtb.apjtb_178_25","volume":"15","author":"SK Yasam","year":"2025","unstructured":"Yasam SK, Subbaraj GK, Vijay D. Naringenin nanoparticles show anti-angiogenic activity in HUVECs and a chick chorioallantoic membrane model and anticancer activity in MCF-7 cells. Asian Pac J Trop Biomed. 2025;15(9):384\u201398.","journal-title":"Asian Pac J Trop Biomed"},{"issue":"3","key":"641_CR290","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1021\/acs.molpharmaceut.8b01123","volume":"16","author":"Y Sun","year":"2019","unstructured":"Sun Y, Li X, Zhang L, Liu X, Jiang B, Long Z, et al. Cell permeable NBD peptide-modified liposomes by Hyaluronic Acid coating for the synergistic targeted therapy of metastatic inflammatory breast cancer. Mol Pharm. 2019;16(3):1140\u201355. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b01123.","journal-title":"Mol Pharm"},{"issue":"5","key":"641_CR291","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.biomaterials.2013.10.074","volume":"35","author":"S Barui","year":"2014","unstructured":"Barui S, Saha S, Mondal G, Haseena S, Chaudhuri A. Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature. Biomaterials. 2014;35(5):1643\u201356. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.10.074.","journal-title":"Biomaterials"},{"issue":"1","key":"641_CR292","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01623-2","volume":"20","author":"J Xia","year":"2022","unstructured":"Xia J, Zhang S, Zhang R, Wang A, Zhu Y, Dong M, et al. Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes. J Nanobiotechnol. 2022;20(1):414. https:\/\/doi.org\/10.1186\/s12951-022-01623-2.","journal-title":"J Nanobiotechnol"},{"key":"641_CR293","doi-asserted-by":"publisher","unstructured":"Xian P, Zou L, Zhang J, Pan X, Song Y, Nan Y, et al. Precision targeted cancer-associated fibroblast nano-regulator enhanced chemo-immunotherapy for triple-negative breast cancer. Biomaterials. 2026;326:123679. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123679","DOI":"10.1016\/j.biomaterials.2025.123679"},{"issue":"13","key":"641_CR294","doi-asserted-by":"publisher","first-page":"8069","DOI":"10.1039\/d4nr05418k","volume":"17","author":"R Rui","year":"2025","unstructured":"Rui R, Li Y, Liu Y, Li X, Zhou G, Zhao C, et al. Nanoassemblies of the redox paclitaxel prodrug with the natural active ingredient dihydroartemisinin for therapy of breast cancer. Nanoscale. 2025;17(13):8069\u201383. https:\/\/doi.org\/10.1039\/d4nr05418k.","journal-title":"Nanoscale"},{"key":"641_CR295","doi-asserted-by":"publisher","unstructured":"Han B, Wang T, Xue Z, Wen T, Lu L, Meng J, et al. Elemene nanoemulsion inhibits metastasis of breast cancer by ROS scavenging. int j nanomedicine. 2021;16:6035\u201348. https:\/\/doi.org\/10.2147\/ijn.S327094","DOI":"10.2147\/ijn.S327094"},{"issue":"1","key":"641_CR296","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03638-x","volume":"23","author":"W Pan","year":"2025","unstructured":"Pan W, Li C, Zhou X, Liu W, Liu J, Lin Q, et al. Dectin-1-targeted pH-responsive liposomal nanoplatform delivering Plantago Asiatica L. acidic polysaccharide for immunomodulation and immunosuppressive breast cancer microenvironment reprogramming. J Nanobiotechnol. 2025;23(1):597. https:\/\/doi.org\/10.1186\/s12951-025-03638-x.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"641_CR297","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1080\/10717544.2021.1960926","volume":"28","author":"F Guo","year":"2021","unstructured":"Guo F, Yu N, Jiao Y, Hong W, Zhou K, Ji X, et al. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer. Drug Deliv. 2021;28(1):1709\u201321. https:\/\/doi.org\/10.1080\/10717544.2021.1960926.","journal-title":"Drug Deliv"},{"key":"641_CR298","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113614","volume":"381","author":"JH Chen","year":"2025","unstructured":"Chen JH, Zhao CL, Zhang J, Cheng JW, Hu JP, Yu P, et al. Enhancing immunogenicity and release of in situ-generated tumor vesicles for autologous vaccines. J Control Release. 2025;381:113614. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113614.","journal-title":"J Control Release"},{"issue":"10","key":"641_CR299","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1172\/jci137552","volume":"130","author":"EC de Heer","year":"2020","unstructured":"de Heer EC, Jalving M, Harris AL. HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. J Clin Invest. 2020;130(10):5074\u201387. https:\/\/doi.org\/10.1172\/jci137552.","journal-title":"J Clin Invest"},{"key":"641_CR300","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100821","volume":"32","author":"H Li","year":"2022","unstructured":"Li H, Sun X, Li J, Liu W, Pan G, Mao A, et al. Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1\u03b1\/miR-494\/Survivin signaling pathway. Neoplasia. 2022;32:100821. https:\/\/doi.org\/10.1016\/j.neo.2022.100821.","journal-title":"Neoplasia"},{"issue":"4","key":"641_CR301","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/cbin.12123","volume":"48","author":"W Zhao","year":"2024","unstructured":"Zhao W, Ma J, Zhang Q, Zhang H, Ma W, Li S, et al. Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells. Cell Biol Int. 2024;48(4):496\u2013509. https:\/\/doi.org\/10.1002\/cbin.12123.","journal-title":"Cell Biol Int"},{"issue":"1","key":"641_CR302","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00779-x","volume":"13","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang J, Yi T, Li H, Tang X, Liu D, et al. Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies. Biomark Res. 2025;13(1):62. https:\/\/doi.org\/10.1186\/s40364-025-00779-x.","journal-title":"Biomark Res"},{"issue":"1","key":"641_CR303","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00838-y","volume":"20","author":"MJ Ansari","year":"2022","unstructured":"Ansari MJ, Bokov D, Markov A, Jalil AT, Shalaby MN, Suksatan W, et al. Cancer combination therapies by angiogenesis inhibitors; a comprehensive review. Cell Commun Signal. 2022;20(1):49. https:\/\/doi.org\/10.1186\/s12964-022-00838-y.","journal-title":"Cell Commun Signal"},{"key":"641_CR304","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00221","volume":"10","author":"Y Haibe","year":"2020","unstructured":"Haibe Y, Kreidieh M, El Hajj H, Khalifeh I, Mukherji D, Temraz S, et al. Resistance mechanisms to anti-angiogenic therapies in cancer. Front Oncol. 2020;10:221. https:\/\/doi.org\/10.3389\/fonc.2020.00221.","journal-title":"Front Oncol"},{"issue":"13","key":"641_CR305","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1177\/1535370220934038","volume":"245","author":"S Roy","year":"2020","unstructured":"Roy S, Kumaravel S, Sharma A, Duran CL, Bayless KJ, Chakraborty S. Hypoxic tumor microenvironment: implications for cancer therapy. Exp Biol Med (Maywood). 2020;245(13):1073\u201386. https:\/\/doi.org\/10.1177\/1535370220934038.","journal-title":"Exp Biol Med (Maywood)"},{"key":"641_CR306","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091102","author":"J J\u00e1szai","year":"2019","unstructured":"J\u00e1szai J, Schmidt MHH. Trends and challenges in tumor anti-angiogenic therapies. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8091102.","journal-title":"Cells"},{"issue":"7","key":"641_CR307","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.trecan.2017.05.002","volume":"3","author":"S Rey","year":"2017","unstructured":"Rey S, Schito L, Wouters BG, Eliasof S, Kerbel RS. Targeting hypoxia-inducible factors for antiangiogenic cancer therapy. Trends Cancer. 2017;3(7):529\u201341. https:\/\/doi.org\/10.1016\/j.trecan.2017.05.002.","journal-title":"Trends Cancer"},{"key":"641_CR308","doi-asserted-by":"publisher","unstructured":"Bertolini I, Perego M, Nefedova Y, Lin C, Milcarek A, Vogel P, et al. Intercellular hif1\u03b1 reprograms mammary progenitors and myeloid immune evasion to drive high-risk breast lesions. J Clin Invest. 2023;133(8). https:\/\/doi.org\/10.1172\/jci164348","DOI":"10.1172\/jci164348"},{"issue":"4","key":"641_CR309","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/15384047.2017.1294288","volume":"18","author":"H Sun","year":"2017","unstructured":"Sun H, Zhang D, Yao Z, Lin X, Liu J, Gu Q, et al. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry. Cancer Biol Ther. 2017;18(4):205\u201313. https:\/\/doi.org\/10.1080\/15384047.2017.1294288.","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"641_CR310","first-page":"1796","volume":"9","author":"W Xie","year":"2019","unstructured":"Xie W, Zhang Y, Zhang S, Wang F, Zhang K, Huang Y, et al. Oxymatrine enhanced anti-tumor effects of Bevacizumab against triple-negative breast cancer via abating Wnt\/\u03b2-Catenin signaling pathway. Am J Cancer Res. 2019;9(8):1796\u2013814.","journal-title":"Am J Cancer Res"},{"key":"641_CR311","doi-asserted-by":"publisher","unstructured":"Cocetta V, Quagliariello V, Fiorica F, Berretta M, Montopoli M. Resveratrol as chemosensitizer agent: state of art and future perspectives. Int J Mol Sci. 2021;22(4). https:\/\/doi.org\/10.3390\/ijms22042049","DOI":"10.3390\/ijms22042049"},{"key":"641_CR312","doi-asserted-by":"publisher","unstructured":"Thomford NE, Senthebane DA, Rowe A, Munro D, Seele P, Maroyi A, et al. Natural products for drug discovery in the 21st century: innovations for novel drug discovery. Int J Mol Sci. 2018;19(6). https:\/\/doi.org\/10.3390\/ijms19061578","DOI":"10.3390\/ijms19061578"},{"key":"641_CR313","doi-asserted-by":"publisher","unstructured":"Shen Y, Du H, Liu F, Gou X, Tao Y, Lan X, et al. Quality control of herbal medicine based on analytical techniques and machine learning: current advances and future perspectives. Phytochem Anal. 2026. https:\/\/doi.org\/10.1002\/pca.70065","DOI":"10.1002\/pca.70065"},{"key":"641_CR314","doi-asserted-by":"publisher","unstructured":"He P, Zhang C, Yang Y, Tang S, Liu X, Yong J, et al. Spectrum-effect relationships as an effective approach for quality control of natural products: a review. Molecules. 2023;28(20). https:\/\/doi.org\/10.3390\/molecules28207011","DOI":"10.3390\/molecules28207011"},{"issue":"11","key":"641_CR315","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2471\/blt.25.293437","volume":"103","author":"Q Chen","year":"2025","unstructured":"Chen Q, Cheng HJ, Bian ZX, Lyu AP, Yang Y, Chan KW. Regulatory frameworks and evidence requirements for traditional, complementary and integrative medicines. Bull World Health Organ. 2025;103(11):696\u2013707c. https:\/\/doi.org\/10.2471\/blt.25.293437.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"641_CR316","doi-asserted-by":"publisher","first-page":"e202200149","DOI":"10.1002\/cbdv.202200149","volume":"19","author":"O Mykhailenko","year":"2022","unstructured":"Mykhailenko O, Buydin Y, Ivanauskas L, Krechun A, Georgiyants V. Innovative GACP approaches for obtaining the quality iris hybrida leaves for the pharmaceutical industry. Chem Biodivers. 2022;19(4):e202200149. https:\/\/doi.org\/10.1002\/cbdv.202200149.","journal-title":"Chem Biodivers"},{"key":"641_CR317","unstructured":"Beressa A, Wariyo A, Chala G, Tefera Y. Analytical method development for quality control and standardization of medicinal plants: a critical review. Res Rev J Herb Sci. 2021;10(1):9\u201320p. Analytical Method Development for Quality Control and Standardization Beressa et al STM Journals. 2021:2."},{"key":"641_CR318","doi-asserted-by":"publisher","unstructured":"Noviana E, Indrayanto G, Rohman A. Advances in fingerprint analysis for standardization and quality control of herbal medicines. Front Pharmacol. 2022;13:853023. https:\/\/doi.org\/10.3389\/fphar.2022.853023","DOI":"10.3389\/fphar.2022.853023"},{"key":"641_CR319","doi-asserted-by":"publisher","unstructured":"Gashaw AD, Desta MA, Yaya EE. A comprehensive review-current development in spectroscopic and chroma tographic techniques for natural product analysis. Results Chem.16:102341. https:\/\/doi.org\/10.1016\/j.rechem.2025.102341","DOI":"10.1016\/j.rechem.2025.102341"},{"key":"641_CR320","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2025.466399","volume":"1761","author":"L Wu","year":"2025","unstructured":"Wu L, Yan J, Hu J, Pang D, Ji Y, Gong D. Full-spectrum HPLC fingerprint with binary evaluation system and chemometrics for herbal medicine quality-efficacy control. J Chromatogr A. 2025;1761:466399. https:\/\/doi.org\/10.1016\/j.chroma.2025.466399.","journal-title":"J Chromatogr A"},{"key":"641_CR321","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.copbio.2013.09.010","volume":"25","author":"N Techen","year":"2014","unstructured":"Techen N, Parveen I, Pan Z, Khan IA. DNA barcoding of medicinal plant material for identification. Curr Opin Biotechnol. 2014;25:103\u201310. https:\/\/doi.org\/10.1016\/j.copbio.2013.09.010.","journal-title":"Curr Opin Biotechnol"},{"key":"641_CR322","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1265178","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Chen Y, Wang L, Liu Q, Yang S, Wang C. Advancing herbal medicine: enhancing product quality and safety through robust quality control practices. Front Pharmacol. 2023;14:1265178. https:\/\/doi.org\/10.3389\/fphar.2023.1265178.","journal-title":"Front Pharmacol"},{"issue":"43","key":"641_CR323","doi-asserted-by":"publisher","first-page":"50695","DOI":"10.1021\/acsomega.5c05971","volume":"10","author":"J Naozuka","year":"2025","unstructured":"Naozuka J, de Oliveira AP, de Oliveira HB, Lima LO, Nomura CS. Determination of essential and toxic elements by ICP-MS in herbal medicines. ACS Omega. 2025;10(43):50695\u2013708. https:\/\/doi.org\/10.1021\/acsomega.5c05971.","journal-title":"ACS Omega"},{"key":"641_CR324","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2026.127514","volume":"352","author":"G Peng","year":"2026","unstructured":"Peng G, Xue Q, Liu H, Chen D, Liu Q, Zhang S, et al. Construction of a multidimensional quality evaluation system for Scutellariae Radix: integrated research on chemical components, biological potency, near-infrared spectroscopy technology, and intelligent algorithms. Spectrochim Acta A Mol Biomol Spectrosc. 2026;352:127514. https:\/\/doi.org\/10.1016\/j.saa.2026.127514.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"641_CR325","doi-asserted-by":"publisher","unstructured":"Fimognari C, Lenzi M, Ferruzzi L, Turrini E, Scartezzini P, Poli F, et al. Mitochondrial pathway mediates the antileukemic effects of Hemidesmus indicus, a promising botanical drug. PLoS One. 2011;6(6):e21544. https:\/\/doi.org\/10.1371\/journal.pone.0021544","DOI":"10.1371\/journal.pone.0021544"},{"issue":"2","key":"641_CR326","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41375-023-02093-7","volume":"38","author":"S Suma","year":"2024","unstructured":"Suma S, Suehara Y, Fujisawa M, Abe Y, Hattori K, Makishima K, et al. Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution. Leukemia. 2024;38(2):340\u201350. https:\/\/doi.org\/10.1038\/s41375-023-02093-7.","journal-title":"Leukemia"},{"issue":"8","key":"641_CR327","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1200\/jco.19.01203","volume":"38","author":"CB Ambrosone","year":"2020","unstructured":"Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, et al. Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221). J Clin Oncol. 2020;38(8):804\u201314. https:\/\/doi.org\/10.1200\/jco.19.01203.","journal-title":"J Clin Oncol"},{"issue":"5","key":"641_CR328","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.cpt.2025.02.006","volume":"3","author":"M Devaraji","year":"2025","unstructured":"Devaraji M, Thanikachalam PV. Phytoconstituents as emerging therapeutics for breast cancer: mechanistic insights and clinical implications. Cancer Pathog Ther. 2025;3(5):364\u201382. https:\/\/doi.org\/10.1016\/j.cpt.2025.02.006.","journal-title":"Cancer Pathog Ther"},{"key":"641_CR329","doi-asserted-by":"publisher","DOI":"10.3390\/plants12122350","author":"M Alaouna","year":"2023","unstructured":"Alaouna M, Penny C, Hull R, Molefi T, Chauke-Malinga N, Khanyile R, et al. Overcoming the challenges of phytochemicals in triple negative breast cancer therapy: the path forward. Plants. 2023. https:\/\/doi.org\/10.3390\/plants12122350.","journal-title":"Plants"},{"key":"641_CR330","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153218","volume":"70","author":"T Saghatelyan","year":"2020","unstructured":"Saghatelyan T, Tananyan A, Janoyan N, Tadevosyan A, Petrosyan H, Hovhannisyan A, et al. Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: a comparative, randomized, double-blind, placebo-controlled clinical trial. Phytomedicine. 2020;70:153218. https:\/\/doi.org\/10.1016\/j.phymed.2020.153218.","journal-title":"Phytomedicine"},{"key":"641_CR331","doi-asserted-by":"publisher","unstructured":"Goyal S, Beniwal SK, Agarwal P, Brar RK, Jain P, Kumar HS, et al. Efficacy and safety of curcumin as an adjuvant to standard chemotherapy in advanced and metastatic breast cancer patients: a randomized controlled study. Phytother Res. 2025;39(11):5006\u201324. https:\/\/doi.org\/10.1002\/ptr.70086","DOI":"10.1002\/ptr.70086"},{"issue":"1058","key":"641_CR332","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20150665","volume":"89","author":"H Zhao","year":"2016","unstructured":"Zhao H, Zhu W, Jia L, Sun X, Chen G, Zhao X, et al. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy. Br J Radiol. 2016;89(1058):20150665. https:\/\/doi.org\/10.1259\/bjr.20150665.","journal-title":"Br J Radiol"},{"key":"641_CR333","doi-asserted-by":"publisher","unstructured":"Zhao H, Zhu W, Zhao X, Li X, Zhou Z, Zheng M, et al. Efficacy of epigallocatechin-3-gallate in preventing dermatitis in patients with breast cancer receiving postoperative radiotherapy: a double-blind, placebo-controlled, phase 2 randomized clinical trial. JAMA Dermatol. 2022;158(7):779\u201386. https:\/\/doi.org\/10.1001\/jamadermatol.2022.1736","DOI":"10.1001\/jamadermatol.2022.1736"},{"issue":"9","key":"641_CR334","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1158\/1940-6207.Capr-12-0117","volume":"5","author":"KD Crew","year":"2012","unstructured":"Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, et al. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer Prev Res (Phila). 2012;5(9):1144\u201354. https:\/\/doi.org\/10.1158\/1940-6207.Capr-12-0117.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"6","key":"641_CR335","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1080\/01635581.2023.2181735","volume":"75","author":"M Hamidian","year":"2023","unstructured":"Hamidian M, Foroughinia F, Yousefi M, Haghighat S, Haem E. Effects of Panax Ginseng on health-related quality of life in patients with non-metastatic breast cancer: a randomized, double-blind, placebo-controlled clinical trial Ginseng for HRQOL in breast cancer. Nutr Cancer. 2023;75(6):1429\u201337. https:\/\/doi.org\/10.1080\/01635581.2023.2181735.","journal-title":"Nutr Cancer"},{"key":"641_CR336","doi-asserted-by":"publisher","unstructured":"Tocaciu S, Oliver LJ, Lowenthal RM, Peterson GM, Patel R, Shastri M, et al. The effect of undaria pinnatifida fucoidan on the pharmacokinetics of letrozole and tamoxifen in patients with breast cancer. Integr Cancer Ther. 2018;17(1):99\u2013105. https:\/\/doi.org\/10.1177\/1534735416684014","DOI":"10.1177\/1534735416684014"},{"key":"641_CR337","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.phymed.2018.09.178","volume":"54","author":"C von Hagens","year":"2019","unstructured":"von Hagens C, Walter-Sack I, Goeckenjan M, Storch-Hagenlocher B, Sertel S, Els\u00e4sser M, et al. Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33\/2). Phytomedicine. 2019;54:140\u20138. https:\/\/doi.org\/10.1016\/j.phymed.2018.09.178.","journal-title":"Phytomedicine"},{"key":"641_CR338","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.111367","volume":"200","author":"D Dhillon","year":"2026","unstructured":"Dhillon D, Jain M, Singh AK, Muthukumaran J. Systems-level exploration of Withania somnifera-derived phytochemicals against breast cancer: a network pharmacology and molecular modeling approach. Comput Biol Med. 2026;200:111367. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111367.","journal-title":"Comput Biol Med"},{"issue":"11","key":"641_CR339","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/s1875-5364(25)60941-1","volume":"23","author":"X Shao","year":"2025","unstructured":"Shao X, Chen Y, Zhang J, Zhang X, Dai Y, Peng X, et al. Advancing network pharmacology with artificial intelligence: the next paradigm in traditional Chinese medicine. Chin J Nat Med. 2025;23(11):1358\u201376. https:\/\/doi.org\/10.1016\/s1875-5364(25)60941-1.","journal-title":"Chin J Nat Med"},{"key":"641_CR340","doi-asserted-by":"publisher","unstructured":"Roney M, Mohd Hisam NS, Uddin MN, Istiaque Hamim SM, Lim LW, Wong KH. Repurposing of natural products for spinocerebellar ataxia type 3 using integrated network pharmacology and in silico approaches. Sci Rep. 2026;16(1). https:\/\/doi.org\/10.1038\/s41598-025-30652-8","DOI":"10.1038\/s41598-025-30652-8"},{"issue":"6","key":"641_CR341","doi-asserted-by":"publisher","first-page":"549","DOI":"10.20892\/j.issn.2095-3941.2025.0145","volume":"22","author":"G Li","year":"2025","unstructured":"Li G, Shi Q, Wu Q, Sui X. Target identification of natural products in cancer with chemical proteomics and artificial intelligence approaches. Cancer Biol Med. 2025;22(6):549\u201397.https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2025.0145","journal-title":"Cancer Biol Med"},{"key":"641_CR342","doi-asserted-by":"publisher","DOI":"10.1016\/j.eujim.2023.102278","volume":"62","author":"X Duan","year":"2023","unstructured":"Duan X, Zhao T, Wang J, Wang J, Zheng Y. Curcumol targets glutaminase 1 to regulate glutamine metabolism and induce senescence of hepatic stellate cells. Eur J Integr Med. 2023;62:102278.","journal-title":"Eur J Integr Med"}],"container-title":["Natural Products and Bioprospecting"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-026-00641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13659-026-00641-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-026-00641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:03:27Z","timestamp":1790784207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13659-026-00641-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":342,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["641"],"URL":"https:\/\/doi.org\/10.1007\/s13659-026-00641-z","relation":{},"ISSN":["2192-2195","2192-2209"],"issn-type":[{"value":"2192-2195","type":"print"},{"value":"2192-2209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"88"}}